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Abstract 
 
Reprogramming of somatic cells into neurons provides a new approach toward cell-
based therapy of neurodegenerative diseases. Conversion of postnatal astroglia from 
the cerebral cortex of mice into functional neurons in vitro can be achieved by forced 
expression of a single transcription factor. Also skin fibroblasts have been successfully 
reprogrammed into functional neurons yet through the synergistic action of several 
transcription factors. A major challenge for the translation of neuronal reprogramming 
into therapy concerns the feasibility of this approach in adult human tissues. This work 
demonstrates the potential of perivascular cells isolated from the adult human brain to 
serve as a substrate prompted to neuronal reprogramming by forced co-expression of 
neurogenic transcription factors, namely the SRY-related HMG box protein Sox2 and 
the basic helix loop helix (bHLH) mammalian homologue of achaete-schute-1 Mash1 
(also known as Ascl1). The cells used in this study display characteristics of pericytes 
assessed by immunocytochemistry, fluorescence-activated cell sorting (FACS) and 
real time RT-PCR. The presence of neural progenitor cells was excluded by real time 
RT-PCR analysis of mRNAs typically expressed by these cell lineages. Upon 
expression of Sox2 and Mash1, these cells adopt a neuronal phenotype characterized 
by the expression of neuronal markers such us ßIII-Tubulin, MAP2, NeuN, GABA 
and calretinin. Electrophysiological recordings reveal the ability of these cells to fire 
repetitive action potentials and to integrate into neuronal networks when co-cultured 
with mouse embryonic neurons. The pericytic nature of the reprogrammed cells was 
further demonstrated by isolation of PDGFRß-positive cells from adult human brain 
cultures by FACS and monitoring the Mash1/Sox2-induced neuronal conversion by 
time-lapse video microscopy. Genetic fate-mapping in mice expressing an inducible 
Cre recombinase under the tissue non-specific alkaline phosphatase promoter 
corroborated that pericytes from the adult cerebral cortex can be expanded and 
reprogrammed in vitro into neurons by co-expression of Sox2 and Mash1. These 
results demonstrate the feasibility of an in vitro neuronal reprogramming approach on 
somatic cells isolated from the adult human cerebral cortex which could have 
important implications in the development of in vivo direct repair strategies in 
neurodegenerative diseases and brain injury. 
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 Introduction 
Introduction 
 
The central nervous system lacks the ability for self repair, resulting in irreversible loss 
of functional neuronal activity upon injury or disease. However, it has been found that 
two areas of the adult mammalian brain retain neurogenic potential, namely the sub-
ependymal zone of the lateral ventricle and the subgranular zone of the hippocampal 
dentate gyrus; interestingly, new neurons generated throughout lifespan have been 
shown to be of glial origin 
1-4
. Analysis of the reaction of glial cells upon pathological 
conditions has led to the idea that glial cells residing in non-neurogenic regions may de-
dedifferentiate, re-acquiring stem cell properties 
5
. Different approaches for 
development of cell-based replacement therapies have been explored. One approach 
aims at transplanting stem cells which have been previously expanded in vitro and 
specified to differentiate into a target cell type. This strategy relies on an expandable 
source of cells, exemplified by embryonic stem cells which have been differentiated in 
distinct neuronal populations such as midbrain dopaminergic and spinal motoneurons 
6,7
. Another method involving the generation of stem cells by means of transcription 
factor-based reprogramming of somatic cells from the skin (e.g. induced pluripotency) 
overcomes the use of embryos as a source of embryonic stem cells 
8
.  
Adult neural stem cells represent an alternative source of cells for transplantation. 
However, its restricted neurogenic differentiation potential represents a limitation that 
can be overcome by forced expression of fate determinants, i.e. neurogenic transcription 
factors, leading to directed neuronal subtype specification both in vivo and in vitro 
9-13
. 
An alternative approach aims at exploring the potential of endogenous sources within 
the CNS to achieve cell replacement. Along this line, two categories can be considered:  
1, cell recruitment from adult neurogenic regions to pathological areas and growth 
factor treatment 
14,15
 and 2, recruitment of glial cells which are found widespread 
throughout the brain. If the latter approach is taken into account, a transcription factor-
based reprogramming strategy for direct conversion of (astro-)glial to neuronal cells 
might be feasible. In the following section, I will discuss examples of cell-based 
strategies for neuronal replacement purposes at phase I/II clinical trials 
16
 which provide 
academic researchers with useful information regarding the design of direct conversion 
strategies to treat neurodegenerative human diseases.  
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 Introduction      
1.1. New therapeutic strategies in CNS diseases 
 
In order to treat human neurodegenerative diseases, one approach involving 
transplantation of stem cells to restore functionality or to ameliorate the symptoms has 
been proposed. At present, different sources of stem cells for clinical trials are been 
taken into consideration, namely human embryonic stem cells (hESCs), foetal neural 
stem cells and adult neural stem cells. hESCs are derived from the inner cell mass of the 
blastocyst from in vitro fertilization´s excess embryos 
17
. In vitro, these cells can be kept 
in culture for many passages maintaining a normal karyotype (number and appearance 
of chromosomes), generating identical copies of themselves and potentially being 
differentiated into any (e.g. neural) cell lineage 
18,19
. However, undifferentiated hESCs 
may generate teratomas upon transplantation 
20
. Foetal neural stem cells are obtained 
from human foetal post-mortem tissue. In vitro, these cells can also be passaged 
extensively, however to a lesser extent as compared to hESCs, and can be efficiently 
differentiated into neurons and astrocytes 
18
. In vivo, upon transplantation in the adult 
rodent brain, these cells generate large number of neurons with lower risk of teratoma 
formation 
17,21,22
. Adult neural stem cells are derived from adult brain biopsy or post-
mortem tissue. Both in vivo and in vitro, adult neural stem cells show a limited 
differentiation capacity compared to hESCs and foetal neural stem cells 
23
.  
Two main cell-based strategies to treat neurodegenerative diseases involving the use of 
stem cells have been proposed: 1, delivery of bioactive molecules such as neurotrophic 
factors and neurotransmitters; and 2, approaches for cell replacement of neuronal and 
glial cells. I will describe recent reports on stem cell-based phase I clinical trials 
concerning both approaches: 
Neurodegeneration proceeds with gradual neuronal cell loss and, subsequently, 
functional impairment. Stem cells can be used to deliver therapeutic molecules such as 
(a) neurotrophic factors and cytokines which may enhance regeneration, reduce cell 
damage and scar formation, and could stimulate neuronal process outgrowth and (b) 
enzymes for replacing mutated biochemical pathways 
16
. One example of this approach 
is the clinical trial performed on infant patients suffering Batten’s Disease, a fatal 
lysosomal storage disease in which a genetic defect leads to abnormal accumulations in 
lysosomes, leading to neuronal cell death 
24
. Transplantation of human foetal neural 
stem cells (HuCNS-SC
®
 StemCells, Inc) into immuno-deficient palmitoyl protein 
thioesterase-1 (PPT1) knockout mouse, which resembles the human disease 
24
, resulted 
in the preservation of hippocampal and cortical neurons as well as delayed motor 
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coordination loss 
24
. The transplanted cells were able to migrate from the transplantation 
site and to produce the missing PPT1 enzyme, resulting in reduced lysosomal 
accumulation 
25
. This experiments set the rationale for starting a clinical trial phase I 
study enrolling six paediatric patients with Batten’s Disease in a dose increasing 
manner: three patients received a dose of 500 million cells, while in the case of the other 
three, one billion cells were transplanted. The surgery, involving several bilateral neural 
stem cell transplants was well tolerated and followed by 12 months of immune-
suppression. Post-mortem analysis showed donor cell survival in one subject who died 
11 months after transplant. This clinical trial phase I study showed for the first time 
human safety data with a neural stem cell product 
16
. 
Another disease in which clinical trials following a stem cell therapeutic approach have 
been performed is Parkinson´s Disease (PD). This pathology is characterized by the loss 
of dopaminergic neurons in the substantia nigra pars compacta (SNc), which project to 
the striatum where motor function is regulated 
26
. As dopaminergic neurons die, the 
levels of the neurotransmitter dopamine decline, leading to symptoms such as tremor, 
rigor and postural instability 
26
. A number of patients suffering of PD have been subject 
of foetal cell and tissue transplantation in the caudate-putamen, where dopaminergic 
neurons project to. In some of them, a long-term relief has been reported 
26
. Post-
mortem analysis has revealed that an immature type A9 dopaminergic neuron may be 
responsible for these beneficial effects 
27
. These studies have also shown that the 
transplanted cells may acquire pathological hallmarks of the disease, such as the 
formation of α-synuclein aggregates, indicating host-to-donor spread of pathology 
28
.  
All together, stem cell-transplantation data indicates that neurodegenerative diseases can 
be treated using cell-based strategies. At the moment, basic research laboratories are 
developing alternative methods based on the use of somatic cells. One approach is the 
isolation of easily accessible (i.e. from skin) somatic cells from the patient, 
differentiation in vitro into the desired cell type and subsequently (autologous) 
transplantation into the diseased area. Alternatively and based on the related 
developmental cell origin (embryonic germ layers), the potential of cells present in the 
disease tissue as direct target for in situ reprogramming (i.e. astroglia to neuron) is 
presently explored. Both approaches aim at avoiding the use of stem cells which raise 
ethical issues; and risks which transcription factor-driven reprogramming may 
overcome. 
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1.2. Cellular reprogramming 
 
1.2.1. Induced pluripotent stem cells (iPS) 
 
Nuclear transplantation experiments in amphibians have shown that the nucleus of a 
terminally differentiated  cell can be reversed to a pluripotent state, acquiring the ability 
to generate an entire animal 
29
. This reprogramming approach, called somatic cell 
nuclear transfer (SCNT), has also been shown to be possible in mammals, and it is 
exemplified by the generation of “Dolly the sheep” 
30
. These findings suggested that 
molecules present in an unfertilized egg can modify the epigenetic state of chromatin of 
a somatic nucleus and reactivate transcription of genes which are silenced in terminally 
differentiated cells. In 2006, a pioneering study revealed a set of transcription factors 
that could induce pluripotency (iPS) in embryonic fibroblasts, acquiring the potential to 
differentiate into other cell types 
8
. These induced pluripotent cells (iPSCs) resemble 
embryonic stem (ES) cells morphologically (colony formation), display ES marker 
expression patterns, have the ability to form teratomas when transplanted into mice and, 
most rigorously, can give rise to an entire mouse 
8
. Yamanaka´s group first used four 
transcription factors Oct4 (also known as POU5F1), sex determining region Y-related 
High Mobility Group-box 2 (Sox2), Krüppel-like factor 4 (Klf4) and myelocytomatosis 
oncogene (Myc) 
8
. However, depending on the cell type of origin and the efficiency of 
reprogramming, some factors can be omitted. If Myc is not included, reprogramming 
takes place, albeit at lower efficiency 
31
. Interestingly, human fetal and adult murine 
neural stem cells, which express Sox2 endogenously, can be reprogrammed by 
exclusively using Oct4 
32,33
.  
Indeed, Oct4 and Sox2, which interact with each other and form heterodimers, together 
with Nanog play an essential role in the development and maintenance of pluripotency 
in embryonic stem cells, activating and repressing the transcription of a core regulatory 
gene network 
34
. In addition to direct control of transcription, these factors cooperate to 
regulate epigenetic modifiers and microRNAs, and bind to their own promoters 
conferring self-regulation of their own gene transcription levels 
35
. iPS cells can be 
generated from adult human skin fibroblasts 
36
 allowing in vitro disease modeling and 
the development of cell replacement strategies. One example is the generation of motor 
neurons derived from spinal muscular atrophy (SMA) patient-specific iPS, which 
recapitulated the hallmarks of this pathology 
37
. Also iPS from patients with other 
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neurological disorders such as amyotrophic lateral sclerosis (ALS) 
38
, Parkinson´s 
disease 
39
  and Schizophrenia 
40
 have been generated.  
 
1.2.2. Direct lineage conversion 
 
SCNT and iPS approaches have shown that the loss of developmental potential as 
differentiation proceeds can be overcome by exposing terminally differentiated cells to 
suitable reprogramming factors. This suggests the possibility to direct a cell from one 
lineage to a different one by selecting the appropriate combination of transcription 
factors which, by a single reprogramming step, will recapitulate their specific 
developmental role. In the following section, I will describe different examples of 
transcription factor-based direct conversions with special focus on the astroglia-to-
neuron approach as a model for developing neuronal repair strategies.  
 
MyoD and myogenic conversion 
 
Based on the observation that the DNA demethylating agent 5-azacytidine could induce 
to a certain degree myogenic, chondrogenic and adipogenic phenotypes in immortalized 
mouse embryonic fibroblasts 
41
, a screening  of cDNA libraries from 5-azacytidine-
treated myogenic clones lead to the discovery of the basic helix-loop-helix transcription 
factor MyoD 
42
. By forced expression, MyoD is able to convert primary mouse dermal 
fibroblasts in myocytes 
43
 and to induce the expression of skeletal muscle–specific 
genes in diverse cell types. However, while mesodermal cell types could fully down-
regulate their lineage-specific genes, it did not occur when ectodermal (retinal 
pigmented epithelia) or endodermal (liver) cells were exposed to MyoD 
44
 
45
, suggesting 
that MyoD alone was not sufficient to achieve full muscle phenotype conversion. MyoD 
contains a histidine- and cystein-rich domain and a C-terminal amphipathic α-helix 
which are involved in the recruitment of Switch/Sucrose NonFermentable (SWI/SNF) 
chromatin-remodeling complexes to certain MyoD target genes; this property revealed a 
mechanism for lineage determination in muscle development and explains its ability to 
stimulate gene transcription in heterochromatin, which displays a condensed structure 
and is not transcriptionally active 
46,47
. These findings demonstrate for the first time the 
ability of a single transcription factor to activate lineage-specific gene programs outside 
its normal cellular context. 
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B-cell to macrophage conversion 
 
Experiments performed in the haematopoietic system have revealed that transcription 
factor-mediated direct conversion between mature cell types can be achieved 
48
. Forced 
expression of the basic leucine zipper transcription factor CCAAT/enhancer binding 
protein (C/EBP) α or ß in spleen B cells mediates the up-regulation of the macrophage 
marker Macrophage-1 antigen (Mac1) within 4 days 
48
. In addition, gene expression 
analysis of B-cell-derived Mac1-positive cells showed a Pax5-dependent down-
regulation of seven B-cell genes as well as an up-regulation of five additional 
macrophage markers 
48
. Functional macrophage properties were also reported by 
assessing the ability of reprogrammed B-cells to phagocytise fluorescent beads 
48
. By 
means of an inducible fusion protein in which C/EBP is linked to the estrogen receptor 
(C/EBPα−ER), the conversion of B-cells into macrophages could be temporally 
controlled and led to nearly 100% conversion efficiency within two to three days 
49
. 
Gene expression analysis revealed bidirectional changes in ~2,400 genes already three 
hours after induction, with morphological changes being observed within ten hours 
49
. 
Since most of gene expression changes were independent of protein synthesis and the 
induction of a stable macrophage phenotype was achieved within 48 hours, this worked 
suggested that changes were caused directly by the activity of C/EBP 
49
.  
 
ß-cell to endocrine cell conversion 
 
By combination of gene expression analysis of pancreatic endocrine progenitors or 
mature beta cells 
50
 and loss of function studies of genes involved in beta cell 
specification and differentiation, it has been possible to decipher the set of transcription 
factors that are sufficient to convert in vivo exocrine cells into insulin-producing beta 
cells in mice, namely pancreatic and duodenal homeobox 1 (Pdx1), Ngn3 and 
musculoaponeurotic fibrosarcoma oncogene family protein A (MafA) 
51
. Ectopic 
expression was achieved by infection with adenoviral vectors containing these three 
factors, resulting in the generation of insulin-producing cells throughout the pancreas, 
with an efficiency of 20% of the total co-infected cells being phenotypically beta cells 
51
. Pdx1 is a homeobox-containing transcription factor expressed in pancreatic 
progenitors and mature endocrine cells 
52
. When Pdx1 is ectopically expressed in adult 
murine liver cells it leads to insulin expression and up-regulation of several pancreatic 
genes 
53
 while Pdx1 deletion results in major defects in pancreas formation 
54
. The basic 
helix-loop-helix transcription factor Ngn3 is an essential regulator of endocrine lineage 
8 
 Introduction 
specification during pancreatic development
55
. In fact, the absence of Ngn3 expression 
results in the complete loss of cells of the endocrine lineage in pancreas and intestine 
52
. 
Forced expression of Ngn3 can drive the transdetermination of hepatic progenitor cells 
present in the adult liver into pancreatic neo-islets, which are hormone-producing (e.g. 
insulin) cell clusters 
56
. MafA, a basic leucine zipper transcription factor specifically 
expressed in islet beta cells, regulates insulin transcription by direct binding to the 
insulin promoter and its deletion does not interfere with beta cell specification 
57
. In 
contrast, defects in insulin secretion, corresponding to a diabetic phenotype, can be 
observed when MafA is absent, indicating a role in late stages of beta cell 
differentiation 
58
. When Pdx1, Ngn3 and MafA are ectopically expressed in the adult 
mouse pancreas by adenoviral transduction, insulin expression can be detected three 
days after infection and remains stable for a period of months. Interestingly, no cell 
division was required for this conversion. However, this combination of factors failed to 
reprogram mouse embryonic fibroblasts in vitro and skeletal muscle in vivo into a beta 
cell phenotype 
51
.  In summary, these findings provide an example of direct lineage 
conversion using defined factors in an adult organ with the advantage of no proliferation 
being necessary to achieve reprogramming. 
 
Generation of inner ear hair cells 
 
The inner ear contains five distinct regions of vestibular epithelia: the three cristae and 
the maculae of the utricle and saccule 
60
. The mechanosensory receptor cells of the 
organ of Corti are the so called “hair cells” 
60
. In non-mammalian vertebrates the 
auditory sensory epithelium consists of hair cell and glial-like “support cells", which are 
organized in an alternating manner 
60
. In the mammalian auditory sense organ, namely 
the cochlea, hair cells are organized in a different pattern, with a single row of ‘‘inner’’ 
hair cells and three rows of ‘‘outer’’ hair cells 
60
. The inner hair cells serve as primary 
sensory receptors, while the outer hair cells amplify sound partly through regulation of 
cochlear stiffness 
60
. In mammalians, the support cells acquire different specialized 
morphologies 
60
. In the inner ear, hair cells are surrounded by specialized support cells, 
the so called inner phalangeal cells 
60
. The pillar cells line the space between the inner 
and outer hair cells (tunnel of Corti) and provide structural support to the epithelium 
60
. 
It is believed that the development of the tunnel of Corti and the specializations of the 
hair and support cells may be an adaptation necessary for higher frequency hearing 
59,60
. 
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Spontaneous hair cell regeneration occurs in fish, amphibians and birds 
61-63
. It has been 
shown that support cells can give rise to hair cells during adult stages by trans-
differentiation through up-regulation of the bHLH transcription factor Atoh1 
64,65
, which 
plays an essential role in hair cell development 
66
, and activation of the Notch-signalling 
pathway 
67
. 
In mammalian vertebrates, regeneration of hair cells in the inner ear does not take place. 
Support cells are quiescent (G0 cell cycle phase) in the mammalian inner ear and do not 
resume proliferation upon tissue damage 
68
. Based on the findings from non-mammalian 
vertebrates, several groups have addressed the question whether forced expression of 
Atoh1 in non-sensory cells is sufficient to regenerate hair cells in the mammalian inner 
ear 
60,65
. Indeed, over-expression of Atoh1 in support cells of the inner ear of the adult 
guinea pig may promote formation of new hair cells both in normal and lesioned organ 
of Corti, however, appearing only in non-sensory regions of the inner ear 
69
. Further 
experiments revealed that the potential of Atoh1 to reprogram support cells into hair 
cells is restricted to a period of 6 days after lesion 
70
. 
 
1.2.3. Astroglia-to-neuron conversion: Why astroglia? 
 
During the early phases of murine neural development, the neural plate invaginates 
creating the neural tube which at embryonic stage 9 (E9) consists of a single layer of 
neuroepithelial cells lining the ventricle throughout the anterior-posterior axis. As 
neural development proceeds, the neural tube becomes regionalized and subdivided. 
The anterior part of the neural tube gives rise to the telencephalon which is then 
subdivided into a dorsal and a ventral part. The dorsal telencephalon develops into the 
hippocampus, the olfactory bulb and the neocortex. The ventral telencephalon gives rise 
to the basal ganglia and interneurons migrating to cortex, olfactory bulb and 
hippocampus 
71
. Pyramidal neurons of the cortex arise from the dorsal ventricular zone, 
forming a six-layered structure, characteristic of the neocortex 
72
 (Figure 1.1). Neuronal 
differentiation in the murine neo-cortex peaks approximately at the second third of 
gestation.  
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Figure 1.1: Schematic representation of the cortical layer formation. The cortical plate (CP), gives 
rise to the multilayered neocortex (layers I, II/III, IV, V, VI). E, embryonic day; MZ, marginal zone; SP, 
subplate; CH, cortical hem; IZ, intermediate zone; LGE, lateral ganglionic eminence; MGE, medial 
ganglionic eminence; SVZ, subventricular zone; VZ, ventricular zone; WM, white matter (Modified from 
Molyneaux et al, 2007). 
 
An essential role during neurogenesis is played by the so called radial glial cells 
(RGCs). At the initial stage of neurogenesis (E9-10), neuroepithelial cells are 
transformed into radial glial cells. This process is characterized by the down-regulation 
of epithelial features such as up-regulation of markers such as Vimentin, Nestin, BLBP, 
GLAST, Glutamine synthetase, S100ß and GLT-1 
73-76
. Radial glial cells display a 
polarized morphology characterized by a cilium-bearing apical end contacting the 
ventricular fluid, with their basal domain extending towards the meninges and blood 
vessels 
77
 . During the neurogenic phase, two main functions have been described for 
radial glial cells: (1) they are used as a scaffold by migrating neurons from apical 
(ventricular area) to basal (outer layers) positions and, importantly, (2) serve as neuronal 
progenitors 
74,77,78
. Some RGCs can give rise to neurons and glia, being then considered 
as multipotent 
79
. They are also capable of self-renewing by symmetric division, giving 
rise to two RGCs, or asymmetric division, generating one RGC and a fate-restricted 
progenitor 
80,81
. Thus, RGCs display defining stem cell hallmarks and, therefore, are 
considered as embryonic NSCs 
3
. At the end of neurogenesis, radial glia generate 
astrocytes and later oligodendrocytes with differentiation phases peaking at birth and at 
first month of murine life respectively 
82,83
.  
Interestingly, and in contrast to neurons and oligodendrocytes, astroglia retain the 
expression of some radial glia markers such as S100ß, GLAST, Glutamine Synthetase 
and GLT-1 
84
. In addition to their neurogenic and gliogenic functions, radial glia are 
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responsible for generating ependymal cells as well as some astro/radial glial cells which 
function as neural stem cells (NSCs) in the adult brain (aNSCs) 
3,85,86
. Lineage 
relationship between RGCs and aNSCs can be suggested by the following arguments; 
given the heterogeneity of NSCs regarding both their location and the different 
progenies they give rise to, the subependymal zone (SEZ) is considered to be dorso-
ventrally organized 
9,11,87
. Such a regionalization is indeed found in the developing 
telencephalon 
3
. Thus, it can be argued that different types of RGCs may be the founder 
cells giving rise to each class of adult generated neuron and glia.  In further support of 
this idea, regionalized expression of certain transcription factors correlate between the 
embryonic and adult neurogenic areas. For example, the Drosophila distal-less (Dll) 
gene homeodomain transcription factor 2 (Dlx2), which is involved in interneuron 
specification in the developing ventral telencephalon 
88
 is also prominently expressed in 
the ventral SEZ  
9
. Moreover, transcription factors expressed dorsally in the SEZ, such 
as the Paired box protein 6 (Pax6) and Neurogenin2 (Neurog2)  
9,87  
play important roles 
in the developing dorsal telenchephalon 
136
.  
In further support of the direct relationship between RGCs and aNSCs, several 
signalling pathways (e.g. Notch and Sonic Hedgehog) mediating the transition from 
neurogenesis to gliogenesis in the developing cerebral cortex also play a major role in 
the specification of aNSCs 
89
.Notch is a trans-membrane receptor which upon ligand 
binding can be cleaved, releasing Notch´s intracellular C-terminal domain (NICD) into 
the cytosol and acts either as a transcriptional activator or repressor 
90
. Notch signalling 
has been suggested to be involved in the maintenance of stem cell properties in RGCs 
since the expression of NICD1 and NICD3 increases the frequency of neurosphere 
formation from embryonic cortical progenitors 
91,92
. Other studies showed that forced 
expression of hairy and enhancer of split (Hes)1 and 5  (downstream effectors of Notch) 
impairs neurogenesis in the developing cortex through repression of the proneural genes 
Neurogenin 1 (Neurog1) and mammalian homologue of achaete-scute 1 (Mash1) 
93,94
. 
On the contrary, expression of an active form of Notch1 or Notch3 increases the 
generation of parenchymal astrocytes and ependymal cells 
91,95
. Interestingly, activation 
of Notch signalling has been shown to be required for survival and proliferation of 
aNSCs 
96
. Along this line, notch signalling has been suggested to determine the number 
of stem cells both in vivo and in vitro 
97
.  
Another pathway playing a critical role in both RGCs and aNSC is Sonic hedgehog 
signalling. Upon ablation of ciliary genes in RGCs and, subsequently, defective Sonic 
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Hedgehog signalling, aNSCs are not formed 
98
. There are suggestive evidences that a 
small population of RGCs in the developing brain may respond to the morphogen Sonic 
Hegdehog, establishing the two major neurogenic compartments in the adult brain 
99
. In 
both areas of adult neurogenesis, Sonic hedgehog is required for maintenance and 
proliferation of adult stem cells 
98,100,101
. 
In addition, aNSCs retain the expression of RGCs defining markers such as S100ß, 
GLAST, Glutamine Synthetase and GLT-1 
3,84,102
. Adult neural stem cells residing in 
the subgranular zone of the hippocampal dentate gyrus resemble morphologically RGCs 
due to their elongated radial morphology, while stem cells located at the subependymal 
zone of the lateral ventricule contact the ventricle via a single cilium, as RGCs do 
103
. 
Interestingly, non-neurogenic parenchymal astroglia, which are originated from RGCs 
during development, share expression of proteins typically found in both neurogenic 
RGCs and aNSCs such as S100ß, GLAST, Glutamine Synthetase and   GLT-1 
84
. Thus, 
if parenchymal astroglia are direct progeny of RGCs and share many features with both 
RGCs and aNSCs, it may be possible that these non-neurogenic glial cells harbor some 
degree of stem cell potential 
84
. Under physiological conditions, astroglia carry out 
important functions such as regulation of synapse formation and homeostasis, blood 
brain barrier formation and maintenance, and metabolic support of neurons 
104
. Notably, 
upon acute brain injury parenchymal astroglia up-regulate the expression of the glial 
acidic fibrillary protein (GFAP), which is also found in aNSCs in both neurogenic 
regions, and resume proliferation hence reactivating some stem cell properties 
5,84
. 
 
Neurogenic transcription factors involved in astroglia-to-neuron conversion 
 
Based on the fact that radial glial cells give rise to neurons during mouse cortical 
development  
105,106
 and the resemblance of stem cells residing in the adult neurogenic 
niches to astroglial cells 
1,107
, the group of M. Götz  addressed the question whether 
astroglial cells from adult stages and non-neurogenic regions could be converted to 
neurons by forced expression of neurogenic fate determinants. Expression of Pax6 in 
astroglial cultures from postnatal mouse cortex resulted in up-regulation of neuronal 
markers 
108
 suggesting the potential of astroglia to adopt a neuronal phenotype. Further 
studies demonstrated the ability of other transcription factors with essential roles during 
nervous system development such as Ngn2 and Mash1 to instruct neurogenesis in 
postnatal astroglia in vitro 
109,110
. These neuronal cells are capable of generating 
repetitive action potentials and receive synaptic inputs 
109
. Later, by means of stronger 
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and persistent expression of Ngn2 or Mash1 and/or Dlx2 (a ventral telencephalic down-
stream effector of Mash1 
88
), through silencing-resistant retroviral constructs, astroglia-
derived neurons were shown to form functional synapses 
110
. By this approach, the 
neurotransmitter identity of the converted cells could be tightly controlled. Indeed, 
while Ngn2-expressing neurons are directed towards an excitatory glutamatergic 
phenotype, Mash1/Dlx2-expressing cells display an inhibitory GABAergic identity 
110,111
, recapitulating the function of these transcription factors during forebrain 
development. The efficiency of conversion by forced expression of Ngn2 is higher than 
following expression of Mash1 or Dlx2 alone. Combination of Mash1 and Dlx2, 
however, results in efficiencies close to 90%. Cell division is not required to achieve 
neuronal conversion following ectopic expression of neurogenic fate determinants, 
demonstrated by time-lapse video microscopy of transfected cells, indicating direct 
conversion across cell lineages without reverting to an intermediate progenitor stage. 
The astroglial identity of the cultures could be addressed by genetic fate mapping in 
tamoxifen-inducible GLAST:CreERT2/Z/EG transgenic mice 
112
 which allows 
identification of astroglial lineage based on gene reporter expression. Furthermore, 
astroglia derived from the injured cortex of adult mice could be converted to neurons, 
yet upon culturing in neurosphere conditions 
110
. This work indicates the amenability of 
astroglial cells to adopt a neuronal phenotype upon forced expression of neurogenic 
transcription factors. Moreover, it suggests that the use of developmentally related cell 
lineages for the design of cell-based replacement strategies may be beneficial when 
aiming at fully functional conversions. In this particular case, it suggests the possibility 
to use cells present in the injured cerebral cortical tissue, by-passing transplantation 
steps.  
Importantly, these experiments pointed at the essential role of the transcription factor 
Sox2, since its expression in both postnatal astroglia and neurospheres suggested a link 
between the use of a single transcription factor and the generation of functional neurons 
110
. 
 
SRY-related HMG box 2 (Sox2): Role in neural development 
 
Sox2 is expressed at high levels in progenitor and neural stem cells both during 
embryonic development and adulthood 
113
. Ectopic expression of Sox2 in embryonic 
stem (ES) cells alters their differentiation towards neuroectoderm, displaying reduced 
mesodermal and endodermal fate commitment 
114
. Constitutive expression of Sox2 
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inhibits neuronal differentiation thus maintaining their features of neural progenitors. In 
contrast, Sox2 inhibition results in precocious neuronal differentiation 
115,116
. 
Furthermore, Sox2 plays a critical role in early development indicated by the embryonic 
lethality of Sox2 deletion in mice 
117
. In order to study the functions of Sox2 in later 
stages than early embryonic, different genetic approaches involving conditional 
disruption have been generated. Crossing Sox2 floxed mice with Nestin-Cre resulted in 
survival up to neonatal stages, allowing the study of the role of Sox2 in the developing 
brain. Conditional deletion of Sox2 in neural progenitor cells results in enlargement of 
the lateral ventricles, indicating a role of Sox2 in maintaining neural progenitor cell 
populations during brain development  
118
. An alternative conditional deletion approach 
results in the impairment of the neuronal program from E12.5 
119
. Sox2-deficient mice 
lived for few weeks after birth and showed minor brain defects, however the 
hippocampus lacked neural stem cells and therefore adult neurogenesis, resembling the 
effects of late Sonic Hedgehog (Shh) loss. Interestingly, GLI family zinc finger 2 (Gli2), 
a Shh downstream effector, regulates Sox2 levels in neural stem cells 
120
. This suggests 
a positive feedback loop in which Sox2 activates Shh signaling, which in turn stimulates 
Sox2 expression through the activity of Gli2 
120
; thus maintaining an undifferentiated 
state in neural stem cells. In the adult brain, Sox2 is also expressed in neural stem cells 
present in the neurogenic niches, the subventricular zone  
121
 and the dentate gyrus of 
the hippocampus 
122
. An enhancer deletion of the Sox2 gene results in a lower 
expression of Sox2 in heterozygous animals and consequently a reduction in the number 
of proliferating neural progenitors as well as several significant brain defects 
121
. This 
finding suggests a critical role of Sox2 in stem cell maintenance in the neurogenic 
niches of the adult mammalian brain.  
 
Molecular mechanism of action of Sox2 
 
The neuroepithelium forms shortly after embryo implantation, temporally coinciding 
with the process of gastrulation 
81
. Cells present in the neuroepithelium are referred as 
neural stem cells and give rise to the major cell types forming the CNS, namely 
neurons, astrocytes and oligodendrocytes 
81,123
. Regulation of neural stem cell self-
renewal and differentiation is controlled by multiple cell-intrinsic regulators and 
extracellular signals 
123
. One of these intrinsic factors is the SRY-related HMG-box 
transcription factor Sox2 whose molecular mechanism in stem cell maintenance, self-
renewal and differentiation is described. 
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The sex determining region of Y chromosome-box containing 2 (Sox2) belongs to the 
family of Sox proteins, characterized by the presence of a high-mobility group 
124
, its 
DNA binding domain formed by three L-shaped alpha helices which interact with the 
minor groove of DNA. This interaction widens the minor groove, resulting in DNA 
bending 
125
. According to the model of activity in transcriptional regulation, binding of 
a Sox protein alone to a regulatory region of a gene does not activate gene transcription, 
but cooperation with a specific partner transcription factor which binds to a nearby site 
can create a functional complex, promoting transcriptional activation (Figure 1.2). A 
specific sequence flanking the Sox binding site and an available partner factor in the cell 
determines the activation of a lineage specific transcriptional program 
126
. In ES cells, 
the complex formed by Sox2 and the class V POU (acronym derived from the names of 
three transcription factors, the pituitary-specific Pit-1, the octamer-binding proteins Oct-
1 and Oct-2, and the neural Unc-86 from Caenorhabditis elegans)  transcription factor 
Oct3/4 controls self-renewal and pluripotency 
127
. The Sox2-Oct3/4 pair has been 
shown, together with other transcription factors, to induce pluripotency in somatic cells, 
giving rise to the so called induced pluripotent stem cell (iPSC) technology 
8
.  
Sox2 expression remains high in the neural primordium and is regulated by an array of 
different enhancers, which reflect the local regulatory mechanisms during development 
128
. During CNS development, Sox2 interacts with POU factors to activate genes 
characteristic of neural stem cells such as nestin  
129
. As development proceeds, the N-3 
enhancer is activated in the diencephalon and optic vesicles (retinal priomordium) in an 
overlapping pattern of expression with Pax6. Indeed, the delta-crystallin DC5 enhancer 
is activated by co-binding of Sox2 and Pax6 
130
, forming an auto-regulatory circuit 
during retinal development 
131
. Along this line, forced expression of Sox2 and Pax6 in 
non-ocular head ectoderm elicits ectopic lens placodal development 
132
. Given that the 
Sox-partner interaction determines which of the different regulatory transcriptional 
programs become activated and play an essential role in cell specification, changes in 
one partner lead to step-wise transitions as development proceeds. One example is the 
transition from ES/inner cell mass state under control of Sox2 and class V POU 
(Oct3/4) factors and the neural stem cell state regulated by Sox2 and class III POU 
factors 
133
.  
Another example is the shift from ventricular zone-located apical progenitors to 
subventricular zone-located basal neural progenitors in the developing spinal cord 
129
. 
Both neural progenitors express the Nestin gene through Nes30, an intronic enhancer 
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activated by the combined action of group B Sox (e.g. Sox2) or group C Sox (e.g. 
Sox11) and class III POU (e.g. Brn2) factors 
129
. In the developing spinal cord, 
ventricular progenitors co-express Sox2 and Brn2, with subventricular progenitors co-
expressing Sox11 and Brn2. This shift may release proliferating Sox2-Brn2 neural 
progenitors from stem cell cycle, inducing the neurogenic mode when progenitors 
express Sox11-Brn2 
134
. 
 
Proneural activity of Mash1 and Ngn2: Neocortical neurogenesis  
 
During mammalian early cortical development, neuroepithelial cells divide 
symmetrically giving rise to two identical cells, thus maintaining the pool of stem cells 
77
. At the onset of cortical neurogenesis, a subset of neural progenitors becomes 
restricted to adopt a neurogenic fate 
74
. This fate restriction is due to an increase in 
activity of proneural basic Helix-Loop-Helix (bHLH) transcription factors 
135
 and a 
reduction of Hes and Id factors  
94
, which antagonize the function of proneural proteins. 
Neurogenesis is controlled by two classes of transcription factors: (1) proneural factors 
(e.g. Neurogenins and Mash1) which initiate neurogenesis and specify the neuronal 
subtype and (2) differentiation factors (e.g. NeuroD) involved in terminal differentiation 
of neurons 
136
. Both types are transcriptional activators which bind DNA as 
heterodimers together with E proteins, encoded by the E2A, E2-2 and HEB genes,  also 
members of the basic Helix-Loop-Helix family of proteins  
136
. E-Proteins (e.g. E47) are 
transcription factors involved in the regulation of neurogenesis versus gliogenesis 
during verterbrate nervous system development 
137
. They form heterodimers with bHLH  
transcription factors such as Mash1 and Ngn2, cooperating to activate genes to induce 
neurogenesis in neural prescursors 
136
. The core hexanucleotide motif CANNTG (E 
box) is recognized by the basic region of bHLH factors (Figure 1.3) 
137
.  
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Figure 1.2: Crystal structure of the Oct1/Sox2/FGF4 ternary complex. The centrally positioned POU-
specific domain interacts with the HMG domain of Sox2.  HMG domain of Sox2 (green); POU domain of 
Oct1 (red); Double stranded DNA (blue); (Modified from Remenyi et al, 2003). 
 
 
Co-activators such as E1A binding protein(P300)/CREB-binding protein(CBP) and 
P300/CBP-associated factor (PCAF) bind to bHLH heterodimers and recruit the basal 
transcriptional machinery 
137
. The acetylating activity of the co-activators promotes 
transcriptional activity by de-condensation of chromatin thus adopting an accessible 
structure for the transcriptional machinery 
138
.  
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Figure 1.3: Structural model for the binding of bHLH transcription factors to DNA. bHLH 
transcription factor (blue); double stranded DNA (green); (Modified from Nakahata et al, 2008). 
 
 
 
 
Proneural protein activity in neocortical development 
 
Proneural factors regulate the early steps of neurogenesis, including cell cycle control, 
neuronal commitment, subtype specification, migration of post-mitotic neurons and 
axonal growth 
139-142
. Neurogenins (Ngn1 and Ngn2) are found expressed in the dorsal 
part of the telenchephalon, while Mash1 is expressed mainly at ventral positions and, in 
a lesser extent, dorsally 
135
 (Figure 1.4). Proneural bHLH factor expression is restricted 
to the ventricular and subventricular zone, being absent in the cortical plate, i.e. the final 
location of terminally differentiated neurons. Neurogenin activity gives rise to 
glutamatergic neurons, while Mash1 specifies GABAergic and cholinergic neuronal 
identity as well as oligodendrocytes 
137
. GABAergic interneurons and oligodendrocytes 
found in the neocortex are born in the germinal zone of the ventral telencephalon and, 
following tangential migratory routes, reach their final destination at dorsal positions 
143,144
. Mash1 regulates the GABAergic phenotype of progenitors in part through direct 
regulation of the Distal-less homeobox genes Dlx1 and Dlx2 (Figure 1.4) 
145,146
. 
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Figure 1.4:  Genetic interactions underlying the regionalization of the mammalian telencephalon. 
Schematic coronal section through the telencephalic vesicles at E12.5 showing dorsal and ventral 
subdomains. Dorsal telencephalic progenitors express high levels of the bHLH transcription factors Ngn1 
and Ngn2, and the homeodomain protein Pax6, whereas ventral progenitors express the bHLH protein 
Mash1 and the homeodomain transcription factors Dlx1 and Dlx2 (Modified from Schuurmans and 
Guillemot, 2002).  
 
Loss-of-function studies have revealed the functions of these proneural proteins in 
telencephalic development. In the Ngn2 knock-out mouse, up-regulation of Mash1 at 
dorsal positions of the telencephalon can be observed, resulting in the generation of 
GABAergic neurons at dorsal positions 
147
. Along this line and by knock-in strategy, 
inserting the Mash1 coding sequence in the Ngn2 locus promotes a change in cell fate in 
dorsal progenitors which adopt a GABAergic phenotype and migrate aberrantly from 
dorsal to ventral locations instead of radially. While their identity is altered, the number 
of neurons remains normal 
148
.  
In the Mash1 knock-out mice, telencephalic ventral progenitors are lost, resulting in the 
subsequent absence of basal ganglia neurons and cortical GABAergic interneurons 
149
. 
On the contrary, when Ngn2 replaces Mash1 at the Mash1 locus, no change in the 
phenotype of ventral progenitors can be observed 
145,150
. These findings demonstrate the 
role of proneural proteins in neuronal subtype specification, while indicating that their  
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activities are cell-context dependent.  In vitro gain of function experiments support the 
above mentioned in vivo findings; ectopic expression of Ngn1 in cultured cortical 
progenitors promotes neuronal differentiation 
151
. Also Mash1 over-expression in mouse 
P19 embryonic carcinoma cells results in up-regulation of neuronal markers such as 
ßIII-tubulin and Neurofilament-M 
152
. Moreover, in vitro retroviral transduction of both 
adult SVZ neural stem cells and cortical postnatal astroglia with Ngn2 or Mash1 results 
in the specification of glutamatergic or GABAergic neurons, respectively 
13,110
. Mash1 
and neurogenins activate Notch signaling by promoting expression of the Notch ligands 
Delta and Jagged, with Notch signaling activity being responsible for maintenance of 
the appropriate number of neural progenitors. Mash1 activates the transcription of the 
Notch ligand Delta1 by synergistically interacting with class III POU proteins (Brn1 and 
Brn2) on the Delta1 promoter
153
. By this mechanism, called lateral inhibition, 
differentiating neurons expressing Delta and Jagged inhibit neurogenesis in adjacent 
progenitors, thus maintaining the pool of multipotent neural progenitors
153,154
. 
Interestingly, in addition to its functions in cell cycle arrest and neuronal differentiation, 
Mash1 also regulates genes involved in cell cycle progression, including canonical cell 
cycle regulators and oncogenic transcription factors. This finding reveals a major role of 
Mash1 in the control of the neurogenic program by coordinating the progression of 
neural progenitors through proliferation, cell cycle exit and differentiation
135
. 
 
Neuronal differentiation by bHLH activity 
 
Terminal neuronal differentiation is controlled by other group of bHLH proteins, 
including neuronal differentiation (NeuroD), NeuroD2 and NeuroD6 
155
. These are 
transcriptional activators and bind to E-box hexanucleotide motifs. They are expressed 
in the cortical plate but not in the ventricular zone 
156
, contrary to proneural bHLH 
proteins. No phenotype can be observed in the neocortex of the single or double 
knockouts, indicating a large redundancy among these factors and possibly the existence 
of undiscovered terminal differentiation factors 
157-159
. 
 
Proneural bHLH factors inhibit astrogliogenesis  
 
The expression levels of proneural proteins peaks during neurogenesis, with astrocyte 
differentiation being characterized by a decrease in proneural gene activity. In fact, 
over-expression of proneural proteins in cortical progenitors in vitro inhibits 
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astrogliogenesis 
151
. In support of this observation, neural progenitors isolated from 
Mash1 or Ngn2 knock-out mice tend to give rise to astrocytes rather than to neurons 
139
. 
Ngn1 blocks cytokine-induced astrocyte formation by disruption of the Signal 
transducer and activator of transcription 3(Stat3)/ homolog of protein SMA and mothers 
against decapentaplegic MAD (Smad)/CBP  transcriptional co-activator complex, 
indicating a way to regulate transcription independent of its DNA binding activity 
151
. 
These findings indicate that proneural proteins may have both activator and repressor 
transcriptional activities.  
The transition of neural precursors cells (NPCs) from neurogenic to astrogenic fate is 
controlled by the polycomb group complex (PcG) which restricts the neurogenic 
competence of NPCs and promotes the fate transition of NPCs by changing the 
epigenetic state of ngn gene loci during development 
160
. In fact, the chromatin state of 
the ngn promoter gradually becomes closed as development proceeds, with 
transcription of ngn genes being reduced at the onset of gliogenesis 
160
. The complex 
ring finger protein 1(Ring1B)/Polycomb Repressor Complex 1(PRC1) suppresses ngn1 
expression at late stages of neocortical development, eliminating the ngn-mediated 
repression of astrogenic genes 
160
. 
 
REST-VP16 
 
An additional reprogramming strategy is based on the role of the repressor element 1 
(RE1)-silencing transcription factor (REST)/neuron-restrictive silencer factor (NRSF) in 
neural tissue. REST/NRSF is a transcriptional repressor that regulates the transitions 
from pluripotent to neural stem/progenitor cell and from progenitor to mature neuron
161
. 
In the transition to neural progenitor cell, REST is degraded to levels that maintain 
neuronal gene chromatin in an inactive state yet poised for expression 
161
. As 
progenitors differentiate into neurons, REST and its co-repressors dissociate from the 
RE1 site, activating transcription of neuronal genes 
161
. Based on this knowledge, the 
use of a fusion protein in which the repressor-recruiting domain of REST is replaced by 
the transcriptional activation domain of the herpes virus protein (VP16) 
162
. This 
approach allows for activation of the target genes that REST is normally repressing 
thereby promoting neuronal differentiation 
163
. 
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1.3. Pericytes as a target for neuronal direct conversion 
 
1.3.1. Introduction 
 
Originally discovered by Charles-Marie Benjamin Rouget in 1873, pericytes or Rouget 
cells were described as contractile cells surrounding the endothelial cells of capillaries. 
The term pericyte was introduced by Zimmerman in 1923 due to their location, as they 
are perivascular cells adjacent to blood microvessels 
164
. The definition of a mature 
pericyte as a cell embedded within the vascular basement membrane of microvessels, 
i.e. capillaries, pre-capillary arterioles, collecting venules and post-capillary venules, 
relies on the electronmicroscopical analysis of this cell type 
165
. Due to this technical 
limitation, the identification of pericytes and their distinction from other perivascular 
cells such as vascular smooth muscle cells (vSMCs), fibroblasts, macrophages, etc. is 
still challenging. Therefore, most of the literature refer to a mixture of mural cells types 
of diverse developmental origins associated to blood microvessels, which can be 
defined by location, morphology and gene expression profile.          
   
1.3.2. Location and morphology of pericytes 
 
Pericytes are found ubiquitously associated to microvessels throughout the mammalian 
organism, extending cytoplasmic processes along the abluminal side of the endothelial 
tube (Figure 1.5). The soma of pericytes is commonly found at branching point of 
capillaries, extending processes in a Y-shape maner along each branch. Most pericytes 
synthesise and share a common basement membrane with endothelial cells 
166
 but many 
examples of incomplete or absent BM coverage can also be found 
167
. Pericyte and 
endothelial cells communicate to each other through peg-socket junctions, the pericyte 
fingers (peg) being inserted into invaginations (socket) of the endothelial cells. These 
junctions, found in membrane evaginations are rich in tight and gap junctions 
168
. 
Another types of contacts between pericyte and endothelial cells are adhesion plaques, 
which are fibronectin-rich and resemble adherent junctions 
169
, and N-cadherin adhesion 
junctions 
170
. 
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1.3.3. Pericyte coverage 
 
The proportion of endothelial coverage by pericytes and its ratio is variable and organ-
specific. In normal tissues, the endothelial-pericyte ratio varies from 1:1 to 10:1 and the 
pericyte coverage of the abluminal surface of endothelial cells represents between 70% 
and 10% 
165
. These differences can be correlated to the intrinsic properties of the 
vascular barrier. For instance, the blood brain barrier, with a very tight control of 
vascular permeability, displays the highest pericyte coverage with a 1:1-3:1 endothelial 
cell-pericyte ratio, covering 30% of the endothelial surface 
171
. In contrast, in skeletal 
muscle, where the permeability of the vascular bed is higher, the ratio appears to be 
100:1 
167
. Large coverage of pericytes is also found in the lower limbs 
165
 and in tissues 
with reduced endothelial turn-over 
167
. 
 
1.3.4. Pericyte identification 
 
No single specific maker to unambiguously identify pericytes has so far been described. 
In addition, all molecular markers are dynamic in their expression depending upon 
species, local anatomy, developmental stage, pathology, in vitro culturing, and can be 
also expressed by other cell types. Some of the validated markers are PDGFRß  
(platelet-derived growth factor receptor-beta) a receptor tyrosine kinase 
172,173
; NG2, a 
chondroitin sulfate proteoglycan 
174,175
; CD13 (alanyl aminopeptidase), a type II 
membrane zinc-dependent metalloprotease 
176
; Desmin, an intermediate filament 
177
;  
CD146 (also MCAM), melanoma cell adhesion molecule 
178
; and αSMA, alpha-smooth 
muscle actin 
179
. NG2 serves as a good example for the heterogeneity of pericyte marker 
distribution as it can be found expressed by arteriolar and capillary perivascular cells 
but it is absent on venular pericytes 
180
.  
 
1.3.5. Pericyte functions 
 
Through physical and chemical interaction with endothelial cells, pericytes promote 
vessel stability. Both cell types synthesize and secrete growth factors that promote their 
mutual survival. Mutant mice deficient for PDGF-B/PDGFRß lack mural cells on the 
vasculature resulting in endothelial hyperplasia, abnormal endothelial ultrastructure, as 
well as increased capillary diameter and transendothelial permeability 
181
. Capillary 
constriction mediated by pericytes in response to the addition of vasoactive substances 
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and neurotransmitters has been reported both in vivo and ex vivo 
182,183
. However, 
convincing evidences for in vivo control of blood flow by pericytes at the capillary level 
are lacking, in part due to the difficulties to identify pericytes in living specimens. 
 
1.3.6. Developmental origin of pericytes 
 
Lineage-tracing experiments have revealed that mural cells have diverse developmental 
origins, exemplified by vSMCs present on the aorta and its proximal branches which are 
originate from the secondary heart field, neural crest, mesodermal somites and 
splanchnic mesoderm 
184
. By generation of chick-quail chimeras, a neuroectodermal 
origin for mural cells in the head region has been suggested 
185,186
. Additional support 
for a neural crest origin of mural cells in the CNS has been provided by marker 
expression analysis in mice (Figure 1.5) 
187
. In contrast, mural cells found in lung, liver, 
heart and gut have a mesodermal origin 
188-191
. 
 
 
Figure 1.5: Origin of pericytes in the CNS. The embryonic sources of pericytes include (1) 
neuroectoderm-derived neural crest cells, which give rise to pericytes of the forebrain and (2) mesoderm-
derived mesenchymal stem cells, which give rise to pericytes in the midbrain, brain stem and spinal cord 
(Modified from Winkler, Bell and Zlokovic, 2011). 
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1.3.7. Pericytes at the blood-brain barrier  
 
The vascular bed in the CNS is characterized by a high resistance to the passive 
transport of molecules and cells present in the blood. The neurovascular unit is the 
structure that confers this impermeability to the healthy CNS and is formed by the tight 
interaction of endothelial cells, pericytes and astrocytes. The brain vasculature is fully 
enwrapped by processes called astrocyte endfeet. Also microglia and neurons take part 
of the blood-brain barrier (BBB) by contacting astrocyte´s end feet with their 
cytoplasmic processes (Figure 1.6) 
192
. Brain vessels harbor pericytes that seem 
different to pericytes found at other organs and display brain-specific marker expression 
193
. Based on genetic manipulations of the PDGF-B/PDGFRß signaling pathway in 
mice, the role of brain pericytes during development and adulthood has been recently 
addressed. During embryogenesis, around a week before astrocyte formation, 
endothelial cells invade the CNS and pericytes are recruited to the nascent vessels, 
playing an essential function in the regulation of the blood-brain barrier formation 
through interactions with endothelial cells 
194
. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6: Cellular constituents of the blood–brain barrier. The barrier is formed by capillary 
endothelial cells, surrounded by a basal lamina and astrocytic perivascular endfeet. Astrocytes provide the 
cellular link to the neurons. The figure also shows pericytes and microglial cells (Modified from Abbott et 
al, 2006).  
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Experiments with adult viable pericyte-deficient mouse mutants have demonstrated the 
role of pericytes in the regulation of permeability of the blood-brain barrier.  Pericytes 
regulate blood-brain barrier-specific gene expression patterns in endothelial cells and 
induce polarization of astrocyte end-feet surrounding CNS blood vessels 
195
. Thus, 
progressive pericyte loss in the aging brain may lead to an increased vessel permeability 
and, subsequently, to neurodegeneration 
196
. At the physiological level, control of the 
local blood flow in the brain in response to neuronal activity may occur by pericyte-
mediated capillary constriction, as suggested by ex vivo experiments performed on 
cerebellar and retinal tissue 
197,198
. Pathological situations such as brain 
ischemia/reperfusion-mediated oxidative stress promotes capillary constriction by 
pericytes, adding supportive evidence for a role of pericytes in blood flow control in the 
brain 
199
.   
 
1.3.8. Pericyte role in fibrosis 
 
Tissues respond to injury through processes of wound healing and repair in order to 
maintain their original structure and functionality. Chronic injury, however, results in 
excessive generation of extracellular matrix components and, subsequently, in scar 
formation and organ malfunction 
200
. Myofibroblasts are αSMA expressing cells 
involved in the process of fibrosis. Some studies of fibrogenesis in liver and kidney 
have suggested that pericyte may be precursors of myofibroblasts under pathological 
conditions  
201,202
. The role of the pericyte as a non glial component of the scar in spinal 
cord injury has been addressed recently. The use of GLAST-CreER transgenic mice, 
previously reported to allow labeling of astrocytes 
112
, has been shown to label a subset 
of pericytes lining blood vessels in the spinal cord parenchyma 
203
. Ultrastructural 
analysis confirmed the location on these cells within the basal laminae, between 
endothelial cells and astrocytes, with the recombined cells representing around 10% of 
the total pericyte population in the adult spinal cord. These cells also expressed markers 
characteristic of pericytes such as PDGFRß and CD13. The authors demonstrated that, 
upon injury, a specific pericyte subtype gives rise to scar-forming stromal cells, 
surprisingly, outnumbering astrocytes. Interfering with the generation of progeny from 
these cells by targeted deletion for ras genes (necessary for cell cycle progression 
during mitosis) resulted in failure to form a scar in the injured tissue 
203
, revealing the 
ability of pericytes to proliferate in the adult spinal cord upon certain stimuli. 
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1.3.9. Pericyte plasticity  
 
One remarkable aspect of pericytes from different organs is their ability to differentiate 
in vitro into diverse cell types such as adipocytes, osteoblasts, chondroblasts, myoblasts, 
etc. suggesting a multipotent stem cell phenotype 
204,205
. The similarities with bone 
marrow (BM) mesenchymal stem cell cultures have led to the idea that pericytes may be 
indeed the organ–specific BM mesenchymal stem cell counterparts 
206
. A deeper 
analysis of this issue will be carried out in the discussion part of this thesis. 
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2. RESULTS 
2.1. Characterization of cultures from the adult human cerebral cortex 
In order to assess the potential of somatic cells from the adult human cerebral cortex to 
be used in cell-based replacement strategies for neuronal repair I collected brain tissue 
directly from the operation room and proceeded to culture cells isolated from it. These 
specimens were derived from surgical approaches through the cerebral cortex to deep-
seated non-malignant lesions such as epileptic foci and non-ruptured vascular lesions. 
Only non-diseased tissue was used in this study; furthermore, no patients with tumors 
were selected for this work. It remains open whether patients suffering epilepsy present 
abnormalities in areas where no pathological hallmarks of the disease can be detected 
which could lead to unexpected phenomena in vitro. Specimens were mostly derived 
from temporal cerebral cortex but included also frontal and parietal tissue due to its 
location, adjacent to the hippocampus, a region which is often the focus of epileptic 
seizures. The tissue samples could easily be identified as cortex due to its characteristic 
convolutions which confers the gyrencephalic appearance to the human brain. The age 
of the patients, in the range of 18 to 65 years old, did not result in obvious changes in 
proliferation or morphology upon culturing. In contrast to reports claiming the isolation 
and expansion of progenitor cells from white matter of the adult human brain as 
neurospheres 
207
, I performed adherent monolayer cultures to avoid the isolation of 
neural stem cells. Attempts to culture cells from adult human brain can be found in the 
literature 
208
, however lacking a systematic characterization of the main population of 
protoplasmic proliferative cells that can be expanded from these samples and applying 
the recurrent term fibroblast to a cell type for which no well characterized marker is 
known. Astroglia can be also found in cultures from adult brain tissue when mild 
dissociation procedures are applied, however they seem to lack the ability to proliferate, 
a limiting condition that makes this cell type not suitable for retrovirally-mediated 
transduction (gene delivery method for over-expression purposes). One cell type which 
so far has not attracted much attention as a potential player in cell-replacement strategies 
is the pericyte, which is part of the neurovascular unit, the blood-brain barrier (BBB), 
and can be isolated from adult human brain autopsy tissue and subsequently cultured in 
vitro 
209
. In this thesis, I provide evidence for the perivascular nature of the main cell 
type with the ability to proliferate in the presence of serum upon mechanical dissociation 
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of healthy adult cerebral cortical tissue while excluding a major contribution of other 
cell lineages.  
 
2.1.1. Immunocytochemical analysis  
 
Astroglia from human adult brain in vitro 
 
Two major populations can be detected by immunocytochemical methods in adherent 
cultures from adult human cerebral cortex, namely astroglia and pericytes, which can be 
distinguished from each other by their distinct morphology and marker expression. Due 
to their size and characteristic morphology, astroglial cells can be readily visualized 
under the fluorescence microscope.  Although astrocytes represent a minor proportion of 
the total cell number it is worthwhile including a section in this thesis to address the 
diversity of this lineage in the adult human cortex, revealed indirectly by in vitro 
culturing. Only when performing mild dissociation (together with a trypsinization step) 
of cortical tissue it is possible to isolate this cell type, suggesting that they are very 
sensitive to mechanical rupture.  
Astrocytes are characterized by the presence of thin elongated and ramified processes, 
radiating from the cell body in a stellate manner, however differences in shape, 
branching complexity as well as in marker expression can be observed in cultured 
astroglial cells. In the adult human cerebral cortex four distinct GFAP-positive astrocyte 
morphologies have been described: a, protoplasmic; b, interlaminar; c, polarized; and d, 
fibrous 
210
. Astroglial cells present in the cultures were visualized by immunostaining 
using various markers typically labeling astrocytes such as the intermediate filaments 
GFAP, Nestin and Vimentin; cytoplasmic proteins like S100ß and Glutamine Synthetase 
84
 and receptors such as the neurotrophin receptor p75
NTR
  
211
 (Figures 2.1, 2.2). I found 
great heterogeneity in the expression of these astroglial markers, with GFAP being 
prominently expressed by most cells displaying astroglial morphology although with 
differences in intensity, indicating a clear diversity among the GFAP-positive 
population. Interestingly, cells with lower levels of GFAP often displayed higher levels 
in the expression of S100ß and Glutamine synthetase (Figures 2.1, 2.2). 
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Figure 2.1: Cultured astroglia from adult human cerebral cortex. A, Immunohistochemistry reveals 
abundant GFAP-positive astrocytes in adult human cortical tissue samples prior to culturing (left, 
overview; right, high magnification view); GFAP (red), DAPI (blue). B, Adult human astroglia 
immunostained for GFAP (red) and S100ß (green) in vitro; DAPI (blue). C, Examples of GFAP-positive 
astroglia in vitro. Scale bars: 100µm. 
 
 
 
31 
 Results 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2: Marker expression diversity among astroglia derived from adult human cerebral cortex. 
A-A’, GFAP (red), S100ß (green), DAPI (blue). B-B’, GFAP (red), Glutamine synthetase GS (green), 
DAPI (blue). C-C’, GFAP (red), Vimentin (green), DAPI (blue). D, Glutamine synthetase GS (red), 
Nestin (green), DAPI (blue). E, P75 neurotrophin receptor P75NTR (red), DAPI (blue). F, P75NTR (red), 
GFAP (green). G, P75NTR (red), Sox9 (green), DAPI (blue). Scale bars: 100µm. 
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In regard to Nestin and Vimentin expression, also certain variability could be observed, 
with the expression levels of these filaments being inversely proportional to the size and 
complexity of the cells (Figure 2.2). I could then identify two types of astroglia in these 
cultures which correspond morphologically to fibrous and polarized astrocytes, 
according to the number of processes emerging from their cell bodies (Figure 2.1). I did 
not find protoplasmic astrocytes, characterized for bearing on average forty radial 
processes with high degree of branching 
210
. In contrast, fibrous astrocytes, displaying a 
stellate morphology with fewer primary processes, are less branched than protoplasmic 
astrocytes, allowing a clear identification. Polarized astrocytes display a unipolar 
neuron-like morphology and they are smaller in size in comparison to fibrous astrocytes. 
Given the length of the main process of the interlaminar astrocytes, it is very unlikely 
that upon dissociation their integrity could be preserved, thus explaining their absence in 
culture. Despite the fact that no proliferation assay was performed, the scarcity of 
astrocytes in these cultures suggests their inability to proliferate in vitro. This data shows 
the feasibility of culturing adult astroglia from the human cerebral cortex, highlighting 
the diversity of this cell lineage both in morphology and in marker expression.    
 
Perivascular cells from human adult brain in vitro 
 
Upon dissociation of adult human cerebral cortical tissue and culturing in the presence 
of serum for a period of 2-3 weeks, proliferating protoplasmic cells originating from 
sphere-like structures (Figure 2.5) can be readily detected in the culture flask. They are 
morphologically very different from astrocytes and have been previously identified as 
fibroblasts 
208
. I performed immunocytochemical analysis for the expression of markers 
of perivascular cells 
205
, namely platelet–derived growth factor receptor ß (PDGFRß), 
Vimentin, α-Smooth muscle actin (SMA), NG2, CD146, CD13, Sox9 and Nestin 
resulting in a major proportion of the analyzed cells being immunoreactive (Figure 2.4, 
2.5). Pericytes are mural cells located at perivascular positions, which typically express 
PDGFRß and NG2, among other markers, however with a high degree of heterogeneity 
depending on their localization and size of the blood vessel (Figure 2.3). Upon 
culturing, the vast majority of the cells express PDGFRß, clearly recognized as a 
membrane bound protein, and Vimentin, an intermediate filament expressed by cultured 
pericytes and fibroblasts. Also NG2, SMA, CD146 and CD13 expression could be 
detected although at variable levels and distribution among the expanded cell population 
(Figure 2-4). Nestin could be detected in the majority of cells; however it is also 
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expressed by glial and neural stem cells (data not shown). NG2 is as well expressed by 
glial cells, but co-localization with SMA indicates a perivascular identity.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3: Marker expression characterization of perivascular cells from the adult human brain in 
vivo. PDGFRß expression in microvessel-associated cells in the adult human cerebral cortex. A, B, NG2 
expression in microvessel-associated cells in the adult human cerebral cortex. C, PDGFRß expression in 
microvessel-associated cells in the adult human cerebral cortex, Microvessels were visualized by CD31 
(green) immunoreactivity; DAPI (blue). Scale bars. 50 µm. 
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Figure 2.4: Immunocytochemical analysis for pericyte marker expression in cell cultures obtained 
from adult human cerebral cortical tissue. A, PDGFRß (red), vimentin (green), DAPI (blue). B 
PDGFRß (red), α-smooth muscle actin (SMA, green), DAPI (blue). C, NG2 (red), SMA (green), DAPI 
(blue). D, CD13 (green), CD146 (red), DAPI (blue). Scale bars: 100µm. 
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Figure 2.5: In vitro sphere-like aggregates in cell cultures derived from adult human cerebral 
cortex. A, Accumulation of DAPI-positive nuclei in a sphere-like aggregate on top of a CD146-positive 
proteoplasmic cell. A’,Confocal section through a CD146-positive sphere-like aggregate (shown in A); 
CD146 (red), DAPI (blue). B-B’’, 3 confocal slices from the bottom to the top of a sphere containing 
CD146- and SMA-positive cells; CD146 (red), SMA (green), DAPI (blue). Scale bars: 100µm. 
 
By the use of antibodies raised against proteins typically expressed by pericytes, I could 
demonstrate the major contribution of protoplasmic cells of perivascular origin in 
cultures isolated from adult human cerebral cortex.  
 
2.1.2. Identity of cell cultures from adult human brain assessed by qRT-PCR 
 
In order to confirm the cellular composition of the cultures, messenger RNA (mRNA) 
was extracted from cell cultures derived from four patients at three different stages, from 
starting point right after expansion up to passage number two. By quantitative RT-PCR 
experiments, the relative proportion of mRNA corresponding to a selection of proteins 
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could be estimated. This technique allowed the confirmation of the perivascular identity 
of the cultures as well as determined the presence of cell lineages which might have not 
been detected by immunocytochemical analysis. As control, mRNA was extracted from 
cerebral tissue corresponding to two patients from which cell cultures were derived and 
used in this analysis. 
 
 
Figure 2.6: Gene expression analysis in adult human cerebral cortical cultures. Real-time quantitative 
RT-PCR analyses for expression of various mRNAs in cultures derived from different patients and 
different passages. Expression was normalized to mRNA levels of GAPDH and compared to the 
expression within the human tissue from which cells were isolated. Messenger RNAs analysed include 
some characteristic for pericytes (PDGFRß, CD146, α-smooth muscle actin (SMA), NG2 (gene name 
Cspg4), intermediate filaments which are also expressed in pericytes (NESTIN, VIMENTIN) and 
astroglia specific mRNAs (GFAP, S100ß).         
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The amount of mRNAs for the pericyte markers PDGFRß, CD146, SMA and NG2 
(Figure 2.6) was examined at three different culturing stages (passages). The 
enrichment of perivascular mRNAs could be explained by an increase on expansion in 
the number of cells pericytic origin, an induction of the higher expression due to the 
culture conditions, or both. In any case, the relative proportion of these transcripts is 
remarkably high, even exceeding the levels of the housekeeping gene, i.e. mRNA levels 
for SMA (Figure 2.6). Notably, all mRNAs analyzed showed lower levels in the 
transcripts extracted directly from cortical tissue, evidencing enrichment for pericytic 
mRNAs upon culturing. Taken together, this data demonstrates the enrichment of 
mRNA expressed by pericytes and indirectly suggests a proliferating behavior of 
pericytes in vitro since the levels compared to original tissue samples dramatically 
increase as the cells expand in number. 
Despite the potential presence of astroglial cells in the cultures derived from cortical 
tissue, the lack of mRNA for GFAP and S100ß (Figure 2.6)  in the analyzed samples 
reveals the virtual absence of astrocytes when tissue dissociation is carried out in 
standard conditions (excluding trypsin) indicating that this cell lineage does not 
participate as a cellular component of the cultures. In contrast, the amount of transcripts 
extracted from the original tissue reveals a strong contribution of astrocytes within the 
organ, highlighted when comparing to the levels of perivascular mRNAs. This data 
indicates that astroglia cannot be expanded under these culture conditions. Furthermore, 
mRNA levels for intermediate filaments such as Vimentin and Nestin were analyzed 
(Figure 2.6), resulting in an increase upon culturing. Of note, they were absent in the 
tissue samples, suggesting that neither tumor formation nor reactive gliosis 
84
 had 
occurred within the tissue prior to culturing.  It has been described that pericytes in vitro 
up-regulate the expression of mRNA for these intermediate filaments 
209
 which, in 
contrast to classical pericyte markers, seems to decrease in level upon passaging.  
One major concern is the presence of neural stem cells in the cultures from adult cortical 
tissue which would undergo neuronal reprogramming much more efficiently than any 
other cell lineages such as pericytes, potentially generating confusion when interpreting 
results. For this reason, qRT-PCR was carried out on the samples for the detection of 
mRNAs typically expressed by neural stem cells such as SOX1 and SOX2 (Figure 2.7). 
All cultures were devoid of transcripts for these neural stem cell markers, arguing 
against the presence of cells with the intrinsic ability to generate neurons.  
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Figure 2.7: Absence of neural stem cell and progenitor gene expression in adult human cerebral 
cortical cultures. Real-time quantitative RT-PCR analyses of genes characteristic of neuronal stem or 
progenitor cells (SOX1, SOX2, OLIG2, ASCL1 (Mash1), PAX6, CD133/Prominin1), oligodendrocytes 
(OLIG2, SOX10) or neural crest progenitors (SOX10). Expression was normalized to mRNA levels of 
GAPDH and compared to the expression within the human tissue from which cells were isolated. 
 
 
 
The tissue samples contained mRNAs for SOX1 and SOX2, consistent with the 
described expression of SOX2 in adult cortical astrocytes 
212
 and in subtypes of adult 
postmitotic neurons, including pyramidal cells of the cerebral cortex, some striatal 
neurons and many thalamic neurons 
121
.   
Other member of the SOX family, SOX10, whose expression marks neural crest-derived 
cells and the oligodendrocyte lineage in the brain 
213
, could not be detected at the mRNA 
level, however abundantly expressed in the cortical tissue samples (Figure 2.7). The 
repressor bHLH transcription factor OLIG2 was also analyzed by RT-PCR to exclude 
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the presence of oligodendrocyte progenitor cells (OPC) in the cultures, since a potential 
neuronal fate under certain conditions has been reported for this cell type 
214
. Indeed, 
while high expression levels of this mRNA were found in the cortical tissue, no 
expression was detected in the cultures, excluding the possibility for a major cellular 
contribution of this lineage (Figure 2.7). Furthermore, examination of the expression of 
markers for neural progenitors or precursor cells committed to a neuronal lineage was 
required to exclude additional cells with intrinsic potential to generate neurons. In fact, a 
marker of stem cells such as CD133/Prominin or Pax6 and Mash1 mRNAs, which are 
expressed by neural progenitors, could not be detected at any passage confirming that 
the cultures were devoid of neuronal progenitors (Figure 2.7).  
SOX9, another SOX family member can be found labeling diverse cell types such as 
astrocytes, chondrocytes, etc and its expression may also be found in pericyte cultures 
when exposed to certain culture media 
215
. Compared to control samples, the levels of 
SOX9 mRNA in the cultures at all analyzed passage stages were very low (Figure 2.7). 
Due to the intimate contact of pericytes and endothelial cells forming the capillaries it is 
possible that the latter could be also taking part in the cellular composition of the 
cultures. For this reason, the levels of mRNA for CD34 which labels cells of endothelial 
and hematopoietic lineage were analyzed (Figure 2.8). Despite a certain amount of 
CD34 mRNA present in the culture samples, a clear reduction is observed upon 
passaging, indicating that an initial minor contribution of these cell types at an early 
time point of culturing does not persist at late stages.   
The neurotrophin receptor p75
NTR
 labels, among other cell types, neuroectodermal 
lineages, such as neural crest-derived cells 
216
. While p75 mRNA can be readily detected 
in all samples, it seems that culturing promotes a down-regulation of this receptor 
(Figure 2.8).   
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Figure 2.8: Gene expression analysis in adult human cerebral cortical cultures. Real-time quantitative 
RT-PCR analyses for expression of two mRNAs in cultures derived from different patients and different 
passages. Expression was normalized to mRNA levels of GAPDH and compared to the expression within 
the human tissue from which cells were isolated. Messenger RNAs analysed consist of p75 neurotrophin 
receptor and and endothelial/hematopoetic lineage specific mRNA (CD34). 
 
 
 
2.1.3. Cellular composition of cultures from adult human brain assessed by FACS 
 
In order to estimate the relative proportion of pericytes within the cultures, and taking 
advantage of their surface marker expression, fluorescence activated cell sorting (FACS) 
was performed. After isolation and expansion, cells from adult human cerebral cortical 
tissue were detached from the culture dish and incubated in suspension with 
fluorescence-conjugated antibodies against proteins expressed by pericytes within the 
cell membrane, at its external surface. The use of membrane-bound proteins as markers 
for sorting allows further culturing without significant cell death. For control, isotype 
(same species as subject antibodies) fluorescence-conjugated antibodies were used and 
the gates properly established in order to eliminate data from cell debris, dead cells, and 
clumps of 2 or more cells. Subcellular debris and clumps can be distinguished from 
single cells by size to avoid false positives (Figure 2.9). Antibodies against PDGFRß, 
CD146 and CD13 were used to detect pericytes and CD34 for identification of 
endothelial/hematopoietic cells. Single or double analysis was performed, combining 
one pericyte marker with CD34. Consistent with the data obtained from the 
immunocytochemical and qRT-PCR analyses, I found that a major proportion of the 
cells present in the cultures expressed PDGFRß, in some occasions above 90% (Figure 
2.9). Given that PDGFRß expression was restricted to perivascular location in the 
histochemical analysis of cerebral cortical tissue used to prepare the cultures (Figure 
2.3), it is very likely that these cells in culture are indeed of pericyte origin. However, in 
order to accumulate additional evidence further analysis was performed on cells isolated 
from 6 patients at different passages (P0 to P4) in comparable experimental conditions 
with PDGFRß, CD146 and CD13 antibodies (Figure 2.9). Around 70% of the cell 
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population showed PDGFRß expression, while CD146 and CD13 were found to be 
expressed to a lesser extent, representing around 40% of the total analyzed cells. While 
this data shows some heterogeneity within the cultures, it is worthwhile mentioning that 
it is well accepted in the literature that expression of markers by pericytes is highly 
dynamic, especially in vitro 
217
.   
        
 
 
 
Figure 2.9: FACS analysis of cell cultures from adult human cerebral cortex: A, Example of FACS 
analysis from an adult human brain culture based on PDGFRß expression. Depicted are the isotype 
controls for establishing the gating conditions for sorting the PDGFRß- and CD34-positive (left and 
middle panel) and the PDGFRß-positive (right) populations. B, Histogram shows the percentage of cells 
positive for cell surface markers characteristic of pericytes. Cells isolated from 6 different patients were 
used (n=6). Error bars show SEM. 
 
 
In addition, variability in the expression levels can be clearly observed by 
immunocytochemical methods. Since FACS analysis was performed in a very stringent 
manner to avoid false positives, it is likely that low expressing cells are excluded from 
positive ones. Of note, the proportion of CD34 positive remained below 1% (Figure 
2.9), adding further evidence for the absence of endothelial/hematopoietic cells in the 
cultures despite the detection of low levels of CD34 mRNA. Taken together, these data 
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demonstrate that cells with a pericytic nature represent the major population within the 
cultures while excluding the presence of astroglia, oligodendrocytes, neural progenitors 
and neural stem cells. Moreover, while low amounts of endothelial/hematopoietic 
mRNA can be detected in the samples (Figure 2.8), the contribution at the cellular level 
is shown to be lower than 1% (Figure 2.9). 
 
2.2. Candidate reprogramming transcription factors  
 
2.2.1. Design of reprogramming Mash1- and Ngn2-expressing constructs 
 
It has been shown that astroglia can be directed to a neuronal phenotype by forced 
expression of neurogenic fate determinants such as Neurogenin2 and Mash1 (also 
known as Ascl1), relying in retrovirally-mediated gene transfer through the use of  
Moloney Murine Leukemia Virus (MMLV)-derived vectors in which expression was 
driven by the long terminal repeat (LTR). These viral sequences also mediate retroviral 
integration into the host genome via a LTR specific integrase 
218,109
.  
 
 
 
 
 
 
Figure 2.10: In vitro conversion of mouse postnatal astroglia into neurons by forced expression of 
CAG-Mash1-IRES-Dsred, CAG-Ngn2-IRES-Dsred or pMX-humanNeurog2-IRES-GFP. A, Control 
transduced astroglia; DsRed (red), ßIII-tubulin (green) DAPI (blue). B, CAG-Mash1 transduced astroglia 
adopt a neuronal phenotype; DsRed (red), ßIII-tubulin (green), DAPI (blue). C, CAG-Ngn2 transduced 
astroglia; DsRed (red), ßIII-tubulin (green) DAPI (blue). D, pMX-humanNeurog2 tranduced astroglia; 
GFP (green), ßIII-tubulin (red) DAPI (blue). 5 days post-infection; Scale bars: 100µm. 
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However, astroglia-derived neurons generated by this approach lacked the ability to 
establish functional synapses. It was speculated that expression of the reprogramming 
factors should occur at faster rate and higher level to achieve a fully mature neuronal 
conversion. For this reason, I generated new retroviral constructs in which expression 
was driven by an alternative promoter, the so called CAG, a combination of the 
cytomegalovirus (CMV) early enhancer element and chicken beta-actin promoter 
219
, 
which has been shown to drive expression at higher levels in mammalian expression 
vectors and are less prompted to silencing. I subcloned the cDNA corresponding to rat 
Mash1 and mouse Ngn2 from the vectors originally used in the astroglia to neuron 
conversion. While rat and human Mash1 share high homology at the protein level 
(99%), suggesting that the rat cDNA may activate transcription in human cells, the 
lower similarities between mouse and human Ngn2 (81%) led me to subclone the human 
Ngn2 cDNA into a retroviral vector in order to ensure reprogramming efficacy in the 
context of human cells. In all cases, the sequence of the neurogenic fate determinant was 
followed by an internal ribosomal entry sequence (IRES) and a reporter gene, either 
DsRed or GFP. The use of reporter is required for detection of transduced cells for 
electrophysiological recording.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.11: Long term expression of neurogenic transcription factors does not impair neuronal 
differentiation. Mouse postnatal astroglia transduced with A, Mash1-IRES-Dsred or B, pMX-
humanNeurog2-IRES-GFP. A, DsRed (red), ßIII-tubulin (green), DAPI (blue). B, GFP (green), HuCD 
(red), DAPI (blue); 30 days post-infection. Scale bars: 100µm. 
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Figure 2.12: In vitro conversion of cells isolated from the rat cerebral cortex of late postnatal age 
into neurons by forced expression of Mash1. A, Cells transduced with pCLIG-Mash1-IRES-GFP give 
rise to ßIII-tubulin (red) positive cells, DAPI (blue); 12 days post-infection. B-B’, Mash1-positive cells 
(GFP) fire repetitive action potentials upon depolarizing step-current injection; 14 days post-infection. C, 
Cells transduced with pMX-REST:VP16-IRES-GFP fail to induce a neuronal phenotype in cells isolated 
from the cerebral cortex of late postnatal rat but express ßIII-tubulin; 12days post-infection; GFP (green), 
ßIII-tubulin (red), DAPI (blue). Scale bars: 100µm: 
 
I then proceeded to test the ability of the CAG retroviral constructs to convert postnatal 
astroglia to neuron (P5). As expected, Mash1 transduced cells adopted a neuronal 
morphology (round cell soma extending long thin processes) and up-regulated the 
expression of the neuronal marker ß-III-tubullin (class III member of the beta tubulin 
protein family  
220
) within 5 days after infection (Figure 2.10). Interestingly and despite 
the lower homology between species in comparison to Mash1/Ascl1, the human Ngn2 
construct showed similar efficacy as mouse Ngn2 in converting mouse astroglia to 
neurons (Figure 2.10). The generated neurons displayed distinct morphologies upon 
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expression of either transcription factor (Figure 2.10) In addition, analysis after long 
term differentiation periods (30 days) showed no toxicity due to over-expression of the 
neurogenic fate determinants, as healthy HuCD-expressing mature neurons 
221
 could be 
found within the cultures (Figure 2.11). Since the goal of this project is to generate 
neurons from cells derived from later developmental stages (ultimately, adult human 
tissue), I tested the ability of retroviral constructs to induce neurogenesis in cells isolated 
from the cortex of rats at later postnatal stages (P25) in a similiar manner as from early 
postnatal mouse. Neither mouse (with 97% homology with rat Ngn2) nor human Ngn2 
(82%) expression resulted in the generation of cells with neuronal morphology or up-
regulation of ß-III-tubulin, suggesting differences in reprogramming efficacy of this 
transcription factor among species and developmental stages. In contrast, transduction of 
rat cortical cultures with Mash1 led to the generation of cells with bipolar elongated 
morphology; their neuronal identity was confirmed by immuno-cytochemistry (Figure 
2.12). Further characterization by means of electrophysiological recordings, showed the 
ability of Mash1-expressing cells to fire trains of actions potentials, indicating the 
potential of Mash1 to elicit functional neurogenesis in other in vitro cellular contexts 
than early postnatal mouse astroglia (Figure 2.12).  
 
 
 
 
 
 
 
 
Figure 2.13: Astrocyte cultures from fetal 
human brain parenchyma transduced with 
Mash1 give rise to neuronal cells. A, B, C, 
D, Marker expression characterization of 
cultures from fetal (20 week old) brain tissue. 
A, GFAP (red), Vimentin (green). B, Nestin 
(red). C, BLBP (red) Vimentin (green). D, 
ßIII-tubulin (red). E-E’, 2 examples of cells 
transduced with pCLIG-Mash1-IRES-GFP, 
giving rise to cells with neuronal morphology 
and ßIII-tubulin expression; GFP (green), ßIII-
tubulin (red). F, Cells transduced with CAG-
Ngn2-IRES-DsRed adopt a neuronal 
morphology and up-regulate ßIII-tubulin; 
DsRed (red), ßIII-tubulin (green). G, Human 
fetal astrocytes fail to adopt a neuronal 
phenotype upon REST-VP16 expression; GFP 
(green), ßIII-tubulin (red). DAPI (blue); Scale 
bars: 100µm. 
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Along this line and to test the ability of Mash1 to convert human cells to neurons, I 
obtained cultures of astrocytes derived from fetal (5 months of gestation) brain 
parenchyma and transduced them with Mash1 or Ngn2. After a period of 10 days I could 
observe the appearance of cells with small soma and branched processes, positive for ß-
III-tubulin expression, indicating that Mash1 (and to a lesser extent also Ngn2) could 
induce a neuronal phenotype in cells of human origin (Figure 2.13). Ultimately, their 
functional neuronal properties could be assessed by electrophysiological recordings, 
displaying the ability to fire a single action potential. In order to reveal the origin of their 
electrical properties, the voltage-gated sodium channel antagonist tetrodotoxin (TTX) 
222
 
was applied to the cells, resulting in blocking of the inward sodium current and so 
corroborating their truly neuronal identity (Figure 2.14). It is worthwhile mentioning 
that the cultures showed a tendency to generate cells of presumptive neuronal identity at 
early passages (p1-p2) (Figure 2.13), yet this phenomenon was no longer observed at 
later stages (p3-p5). Despite the use by the provider company of the term “astrocyte” 
based on the expression of GFAP by ≥95% of the cells, the presence of radial glia, 
which possesses neurogenic potential, cannot be excluded in the cultures. Indeed, the 
cells present in these cultures showed immunoreactivity for GFAP, BLBP, Vimentin and 
Nestin, highly suggestive of a radial glia identity (Figure 2.13).  Regardless of the 
diversity of cell types in this sample, the ability of Mash1 and Ngn2 to promote 
neurogenesis in cells of human origin could be demonstrated.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.14: Mash1 expression induces a functional neuronal phenotype in astrocyte cultures from 
human fetal brain parenchyma. A, Cell transduced with CAG-Mash1-IRES-DsRed. A’, In current-
clamp mode, a cell transduced with Mash1 fire a single action potential, blocked by the sodium channel 
antagonist Tetrodotoxin TTX. B, the TTX-sensitive sodium inward current is shown is voltage-clamp 
mode. 
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2.2.2. E47 
 
Over-expression of E47, one splice variant of the E2A gene, has been shown to prevent 
inhibition of neurogenesis by gliogenic cues in the spinal cord when co-expressed with 
Mash1 
223
. For this reason, I generated a retroviral construct encoding for E47 in order to 
test its neurogenic potential by over-expression in vitro.  
 
 
Figure 2.15: Forced expression of E47 in mouse embryonic cortical cultures and postnatal astroglia. 
A, Cultures from E14 mouse cortex transduced with pMX-E47-IRES-GFP (green), analyzed for the 
expression of ßIII-tubulin (left) or GFAP (right). B, Mouse postnatal astroglia from the cerebral cortex 
transduced with pMX-E47-IRES-GFP (green) analyzed for the expression of ßIII-tubulin (left) or GFAP 
(right). C, Confirmation of E47 protein expression in cells transduced with pMX-E47-IRES-GFP; GFP 
(green) E47 (red). DAPI (blue); Scale bars: 100µm. 
 
 
 
I assessed the neurogenic activity of E47 in neural progenitor cell cultures isolated from 
mouse embryonic cortex at embryonic day 14 (Figure 2.15). Upon retroviral 
transduction, cells positive for the reporter gene (GFP) did not show a marked tendency 
to undergo neurogenesis, being most of the E47-expressing cells negative for neuronal 
markers. Interestingly, many E47-trasnsduced cells were also negative for the astroglial 
marker GFAP. Since the function of E-proteins is context-dependent, I analyzed the 
activity of E47 when over-expressed in cultures of mouse postnatal astroglia (Figure 
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2.15). Similarly as in embryonic cultures, the over-expression of E47 alone did not 
induce a neuronal phenotype in astroglial cells. On the contrary, reporter positive cells 
displayed high levels of GFAP expression, suggesting that E47 alone does not elicit 
obvious changes in the identity of mouse cultured cells. Therefore I proceeded to 
combine the expression of Mash1 and Ngn2 together with E47 (data not shown). I 
observed no major changes in the reprogramming effect compared to Mash1 or Ngn2 
alone. More interestingly, these experiments provided useful information in regard to the 
possibility of use of different factors by combination of retroviral constructs, 
demonstrating the feasibility of this approach.   
 
2.2.3. REST-VP16 
 
The use of a fusion protein in which the repressor-recruiting domain of REST is 
replaced by the transcriptional activation domain of the herpes virus protein VP16, 
allows for activation of the target genes that REST is normally repressing and therefore, 
promoting neuronal differentiation 
163
. The human cDNA for REST was used to 
generate REST-VP16 fusion protein, allowing for retroviral transduction of fetal human 
astrocyte cultures. The REST-VP16 positive cells, which could be detected by 
expression of a reporter gene (GFP), up-regulated the expression of ß-III-tubulin and 
underwent morphological changes to some extent yet they did not acquire a convincing 
neuronal morphology, indicating an incomplete neuronal reprogramming. Occasionally, 
these cells became polarized, extending two processes opposite to each other, with a cell 
body of polygonal/protoplasmic shape (Figure 2.13). Further assessment of the 
reprogramming ability of REST-VP16 on late postnatal rat cortical cultures resulted in 
no major changes in the morphologies of the infected cells; however, immuno-reactivity 
for ßIII-tubulin within the cytoplasm of the reporter-positive cells confirmed the ability 
of this fusion protein to stimulate the expression of neuronal genes 
224
 (Figure 2.12).  
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2.3. In vitro neuronal conversion of adult human brain perivascular 
cultures  
 
2.3.1. Generation of neuronal cells following co-expression Mash1 and Sox2 
 
Following the characterization of the cells present in the cultures obtained from adult 
human brain tissue, I proceeded to assess the response of cells of perivascular nature to 
forced expression of Mash1 or Ngn2. Consistent with the data obtained by 
immunocytochemistry, qRT-PCR and FACS techniques I found that the majority of 
cells transduced with a control retroviral construct encoding for Dsred displayed high 
expression of the pericyte marker PDGFRß  (Figure 2.16). Given the ability of 
retroviral particles to transduce exclusively cells during mitosis, I could reveal the 
proliferative nature of the perivascular-derived cells within the cultures. 
 
 
 
Figure 2.16: PDGFRß-positive cells isolated from the adult human cerebral cortex can be targeted 
with retroviral vectors. A, B, Cells isolated from 2 different patients transduced with a control retroviral 
construct expressing DsRed(red) display PDGFRß (green) expression. 5DPI; DAPI (blue); Scale bars: 
100µm. 
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Figure 2.17: Down-regulation of pericyte markers after forced expression of Mash1 in cell cultures 
from adult human cerebral cortex. A, Control virus and Mash1-coding virus transduced cells derived 
from adult human cortex in vitro and stained for the pericyte-marker PDGFRß. The left panels show 
expression of DsRed protein (red, indicative of transduction) and PDGFRß (green). Right panels show 
down-regulation of PDGFRß (white) expression after forced Mash1 expression, but not in controls; 22 
days post infection (DPI). B, Down-regulation of vimentin in Mash1- but not control-transduced cells; 24 
DPI. C, Forced expression of Sox2 does not alter the cellular morphology nor vimentin expression in 
cultures prepared from the adult human cerebral cortex. Sox2-IRES-GFP (green); vimentin (red); 21 DPI. 
DAPI (blue); Scale bars: 100μm. 
 
 
Interestingly, upon retrovirally-mediated expression of Mash1, a down-regulation in the 
fluorescence intensity corresponding to PDGFRß-immunoreactivity could be readily 
observed among infected reporter-positive cells (Figure 2.17).  
Indeed, in one experiment 86% of control virus infected cells (n= 161) remained positive 
for PDGFRß expression after 22 days, while the proportion of PDGFRß-positive cells 
upon Mash1 transduction showed a reduction to 23% of the total infected cells (n=219). 
Forced expression of Mash1 in perivascular human cultures promote a change in cell 
identity, assessed by down-regulation of a defining marker for pericytes. In order to 
confirm the change in phenotype, I transduced cells with Mash1 and analyzed for the 
expression of Vimentin, which is expressed by brain pericytes in culture 
209
.   
Mash1-positive cells displayed a strong reduction in the expression of vimentin, which 
could not be observed among control transduced cells, corroborating the partial 
reprogramming effect of Mash1 under this culture conditions (Figure 2.17). However, 
as in control cultures, no expression of neuronal markers could be detected in confluent 
perivascular cultures (Figure 2.18). The normal appearing nucleus, assessed by 4',6-
diamidino-2-phenylindole (DAPI) nuclear DNA staining, indicated that the down-
regulation of pericyte markers upon Mash1 expression did not correlate with cell death 
(Figure 2.17). In addition, both control- and Mash1-transduced cells could be cultured 
for periods of several weeks, suggesting no negative effect on survival after prolonged 
retroviral expression.  
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Figure 2.18: Cultures of adult human 
cerebral cortex are devoid of βIII-tubulin 
and Sox2 protein. A, Immuno-
cytochemical analysis of cultures from adult 
human cerebral cortex exhibits no ßIII-
tubulin-immunoreactive cells (green). 
Vimentin (red) staining reveals the 
protoplasmic morphology of these cells. 
Passage 2; 2DIV. Scale bar: 100μm.  B, 
immuno-cytochemical analysis reveals no 
endogenous protein expression of Sox2 in 
proliferative cells, assessed by transduction 
with a control retrovirus; 2DPI. Following 
transduction with a Sox2-encoding 
retrovirus, Sox2 protein expression is 
readily detectable in the nuclei of the 
transduced cells; 21DPI. Same confocal 
settings were used in both conditions. Scale 
bars: 100μm. C, Mash1 expression is 
confirmed by immuno-cytochemical 
analysis. Cells transduced with Mash1-
IRES-DsRed exhibit nuclear staining for 
Mash1 protein (green); 30DPI; Scale bar: 
50 μm. DAPI (blue). 
 
 
 
Of note, the observation that upon Mash1 expression cells did not change in morphology 
could be correlated with the growth of perivascular cells in a confluent manner since, at 
lower cell densities, a consistent change in the shape of some Mash1-positive cells took 
place. Within a period of 10-12 days round cells of 15-20 µm in diameter appeared 
within the Mash1-transduced cell population (Figure 2.20). Importantly, these cells up-
regulated the expression of the neuronal marker ß-III-tubulin, indicating that, under 
these conditions, Mash1 could elicit a further response in direction to a neuronal 
phenotype than in confluent cultures. Following DAPI staining, the nucleus of Mash1-
expressing cells appeared normal, indicating no Mash1-induced toxicity and subsequent 
cell death (Figure 2.18). The long periods of culturing (up to 8 weeks) in which these 
cells could be detected, further demonstrate that the Mash1-reprogramming effect does 
not promote apoptosis. However, none of the cells acquired a neuronal morphology, 
indicating that Mash1 alone was not sufficient to elicit a neuronal phenotype in 
perivascular cells isolated from adult human cortical tissue. Of note, Ngn2 was not able 
to generate changes in cell identity or morphology.  
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Figure 2.19: In vitro conversion of adult human brain pericyte-like cells into neurons. A-A’, 
Induction of a neuronal phenotype following co-expression of Mash1-IRES-Dsred and Sox2 (no reporter) 
in cultures from the adult human cerebral cortex 21 days post infection  and B-B’, Mash1- IRES-Dsred 
and Sox2- IRES -GFP 12 days post infection; C-C’, Combined expression of Mash1 and Sox2 results in 
the generation of cell with neuronal morphologies 42 post infection. A-A’, B-B’, DsRed (red), ßIII-tubulin 
(green). C-C’, DsRed (red), GFP (green) ßIII-tubulin (white). Scale bars: 100μm.  
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Figure 2.20: Quantification of the effect on ßIII-tubulin expression and morphology following 
DsRed only for control, Sox2, Mash1 and combined Sox2 and Mash1 expression. Cells were 
categorized for exhibiting a flat polygonal, round morphology without processes, or neuronal morphology. 
Insets below the histogram show examples of reporter-positive cells and their corresponding expression of 
ßIII-tubulin. Each value represents the mean of ßIII-tubulin- positive cells from 6 different patients. For 
each patient and treatment at least 3 experimental replicates were analysed. For each condition > 1000 
cells were analysed. Error bars are SEM. Scale bars: 100μm. 
 
Therefore, additional factors acting in a synergistic manner might be necessary to 
achieve full neuronal reprogramming. In the process of searching for factors playing 
essential roles in neurogenesis I came across Sox2, a transcription factor expressed from 
early stages during development 
127
, becoming restricted to neural tissue 
117
 and 
remaining expressed up to adulthood in the neurogenic niches of the mammalian brain 
113
. In ES cells, Sox2 governs the pluripotency transcriptional network in synergism with 
Oct4, interacting physically and thereby regulating the expression of pluripotent stem 
cell-specific genes 
34
. Accordingly, these genes have been shown to induce a pluripotent 
state in cells (e.g. skin fibroblasts) isolated at adult stages 
8
, including of human origin 
225
, indicating that Sox2 has the ability to induce transcriptional activation when the right 
partner transcription factors are available.  
Also, previous work has suggested that the presence of endogenous Sox2 expression 
may facilitate neuronal conversion of mouse postnatal astroglia by neurogenic fate 
determinants 
110
 . Bearing in mind that no Sox2 expression could be detected at the 
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protein or mRNA level in perivascular cell cultures from adult human brain (Figures 2.7 
, 2.18), I hypothesized that co-expression of Mash1 and Sox2 might enhance the 
efficiency of neuronal reprogramming. Retroviral expression of Sox2 alone did not elicit 
any changes in morphology or cell identity, assessed by normal expression of vimentin 
(Figure 2.17) and absence of ßIII-tubulin protein (Figure 2.20), or changes in 
proliferation (data not shown), consistent with the requirement of a partner transcription 
factor to allow transcriptional activity by Sox2 
132
. Initially, I used a retroviral vector 
encoding for Sox2 which lacked expression of a reporter gene. Combination of Mash1 
and Sox2 (no reporter) resulted in the generation of cells with neuronal morphology 
positive for ßIII-tubulin expression (Figure 2.19); given the absence of a reporter, a 
construct containing a reporter gene (Dsred or GFP) was constructed which allowed for 
the detection of Sox2-expressing cells (Figures 2.18, 2.19). Notably, in cultures derived 
from 6 patients forced expression of Mash1 and Sox2 significantly increased the 
proportion of ßIII-tubulin positive cells from 10%±4 SEM in Mash1-only transduced 
cells (n=1238 cells analyzed) to 48%±9 SEM in Mash1/Sox2 co-transduced cells 
(n=1500 cells analyzed) (Figure 2.20).  
Strikingly, upon Mash1/Sox2 co-expression cells with identifiable neuronal morphology 
were detected within the ßIII-tubulin–positive population. Confocal microscopy analysis 
revealed that these cells extended thin processes in the range of 100-200µm long 
emerging from a elliptic cell soma of approximately 15-20 µm in diameter, 
morphological features of neurons. In order to assess the reprogramming efficiency of 
the Mash1/Sox2 combination, I established 3 morphological categories among the 
reporter-positive cells expressing ßIII-tubulin, namely a, flat-polygonal; b, round; and c, 
neuronal. Since control or Sox2-only expressing cells did not display ßIII-tubulin 
expression, no quantification or categorizing was carried out on them. I found that 
within two weeks following transduction, most of the Mash1 only-positive cells 
expressing ßIII-tubulin adopted a round morphology. 
55 
 Results 
 
Figure 2.21: In vitro conversion of adult human brain pericyte-like cells into mature neurons. A-A’, 
Cells transduced with Mash1 and Sox2 (white arrowhead) express the neuronal marker NeuN (white). 
Note  the NeuN-negative Mash1-only expressing cell (red arrowhead); 42 days post infection (DPI). B-B’, 
Cells transduced with Sox2 (green) and Mash1 (red) express the neuronal marker MAP2 (white). C-C’,  
D-D’, Adult human pericyte-derived neurons express the inhibitory neurotransmitter GABA and calretinin 
following expression of Sox2 and Mash1. C, GABA immunoreactivity following Sox2 (green) and Mash1 
(red) co-expression. C’, GABA (white); 42 DPI. D, Calretinin immunoreactivity following Sox2 (green) 
and Mash1 (red) co-expression in co-culture with E14 mouse cortical neurons. D’, Calretinin (white); 35 
DPI. DAPI (blue); Scale bars: 100μm. 
 
Virtually none of the cells displayed neuronal processes, indicating a poor 
reprogramming efficiency by Mash1-alone. In contrast, in addition to an increase in the 
56 
 Results 
total number of cells expressing ßIII-tubulin, a significant proportion among the double-
transduced cells (28%±5 SEM) displayed a complex neuronal morphology (Figures 
2.19, 2.20), demonstrating that the combined expression of Mash1 and Sox2 can elicit a 
neuronal phenotype in non-neuronal somatic cells isolated from the adult human 
neocortex. When cultured for periods longer than 4 weeks, markers of mature neurons  
such as the microtubule-associated protein MAP2 
226
 and the neuronal nuclear antigen 
NeuN 
227
  could be detected in double-transduced cells (Figure 2.21). While MAP2 
expression was found along cell soma and processes, NeuN was confined to the nucleus, 
consistent with the expected expression profile of these neuronal markers, adding further 
evidence for a truly neuronal conversion upon Mash1/Sox2 expression. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.22: Efficient neuronal reprogramming of adult human pericyte-like cells by combined 
expression of Sox2 and Mash1 following expansion with or without EGF and FGF2 treatment. 
Histogram shows the number of ßIII-tubulin-positive among reporter-positive cells following expression 
of Mash1-only or Mash1 and Sox2 in combination, with (+) or without (-) the addition of EGF and FGF in 
the culture medium during expansion and prior to retroviral transduction. Cells were categorized for 
exhibiting a flat (F), round without processes (R) or neuronal (N) morphology. For each patient and 
treatment at least 3 experimental replicates were analysed. Statistical significance between culture 
conditions was tested by Student t-test and p-values are shown.  Error bars are SEM. 
 
 
 
Further immunocytochemical characterization of the induced neuronal cells suggested 
the acquisition of an inhibitory interneuron phenotype based on the expression of the 
inhibitory neurotransmitter γ-aminobutyric GABA 
228
 and the calcium-binding protein 
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calretinin 
229
. All analyzed double-transduced cells with neuronal morphology showed 
expression of GABA (14/14 cells), with a subpopulation of these cells (11/18 cells) 
being immunoreactive for calretinin. Lack of expression of the glutamatergic lineage 
marker Tbr1 by Mash1/Sox2-induced neurons adds further evidence for the acquisition 
of an interneuron phenotype (data not shown). 
 
2.3.2. EGF/FGF influence on Mash1/Sox2 induced neuronal reprogramming 
 
To determine whether soluble factors may influence the reprogramming efficiency upon 
forced expression of Mash1 and Sox2, I cultured adult human brain perivascular cells in 
the presence or absence of the mitogens epidermal growth factor (EGF) and fibroblast 
growth factor 2 (FGF2), which are required for the expansion of neural stem cells as 
neurospheres and have to be removed from the culture medium to allow neuronal 
differentiation 
13
. I did not find obvious differences in morphology between cells 
cultured with or without these mitogens. The cells were exposed to the mitogens during 
the expansion phase, with EGF and FGF2 being removed just after retroviral 
transduction. To assess the reprogramming efficiency following treatment with these 
mitogens, I analyzed the ßIII-tubulin-positive cells among the reporter-positive cells 
based on their morphology (a, flat; b, round; c, neuronal) and compared Mash1-only 
versus Mash1/Sox2-combined expression in the presence or absence of EGF and FGF2 
(Figure 2.22) While the proportion of Mash1-only transduced cells that up-regulated 
ßIII-tubulin was higher when expanded with EGF/FGF2, virtually none of them adopted 
a neuronal morphology, indicating that these mitogens do not have a direct influence in 
neuronal differentiation upon expression of Mash1 alone.  
Similarly, the analysis of Mash1/Sox2 expressing cells revealed that only the total 
number of ßIII-tubulin-positive cells was increased upon treatment with EGF/FGF2 but 
not the number of cells that acquired morphological hallmarks of neurons. In both 
conditions, the proportion of neuronal cells was equivalent, representing approximately 
half of the total ßIII-tubulin positive cells, with the differences between both analyzed 
conditions being statistically not significant. The mitogens EGF and FGF2 may 
influence the susceptibility of cells to be targeted with retroviral vectors, which could 
indicate differences in their proliferative behaviour (i.e. cell cycle length) as these can 
only integrate into the genome of host cells during mitosis, resulting in an increase in the 
total number of cells that could be successfully transduced. 
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2.4. Membrane properties of human pericyte-derived neurons 
 
The synergistic action of Mash1 and Sox2 induces, in adult human brain perivascular 
cell cultures, the generation of cells expressing neuron-specific proteins. However, in 
order to claim that this conversion is indeed driving the fate of these cells to a truly 
neuronal identity, a functional electrophysiological analysis of their membrane 
properties is required.  
 
 
 
Figure 2.23: Membrane properties of neurons derived from pericyte-like cells of the adult human 
cerebral cortex. A, Example of a Mash1-only expressing cell. A’, current-voltage relation of the same 
cell (arrowhead), following step-depolarisation. Note the passive response of the cell. B, example of a 
Sox2-only expressing cell. B’, passive current-voltage relation of the same cell. C, example of a cell co-
expressing Sox2 and Mash1 (yellow). C’, following a step-current injection, the cell fires a single action 
potential (red trace) that is blocked by TTX (black trace). C’’, TTX-sensitive sodium currents recorded in 
voltage-clamp. 
 
 
Therefore, the ability of these cells to fire action potentials, a defining characteristic of 
neurons and muscle cells was analyzed. To this purpose, I took advantage of the whole-
cell patch-clamp recording technique that allows the study of excitable cells, such as 
neurons and muscle cells, I started testing the electrical membrane properties of Mash1 
(n=7 cells) and Sox2 (n=6) singly transduced cells. In all cases and consistent with the  
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Figure 2.24: Membrane properties of neurons derived from pericyte-like cells of the adult human 
cerebral cortex co-cultured with mouse embryonic cortical neurons. A, bright field micrograph 
depicts a human PdN (red arrowhead) after 26 days of co-culture with E14 mouse cerebral cortical 
neurons, 46 days following retroviral transduction. B, DsRed fluorescence indicating transduction with 
Mash1 and DsRed-encoding retrovirus. C, GFP fluorescence indicating transduction with Sox2 and GFP-
encoding retrovirus. D, Step current injection in current-clamp results in repetitive action potential firing. 
E, the graph depicts spontaneous synaptic events recorded from the same PdN as shown in D. The 
enlarged trace shows individual synaptic events. E’, The synaptic events are blocked by the application of 
CNQX (10 μM). E’’, Recovery of spontaneous synaptic input following washout of the CNQX. F, High 
magnification view of a single dendrite from a pericyte-derived neuron (magenta) illustrates the high 
density and the distribution of vGluT1-immunoreactive puncta (green). 
 
 
lack of morphological features of neurons of these cells, step-current injection did not 
elicit any action potential firing even at longer periods of culturing (Figure 2.23), 
indicating that neither factor alone induces neuronal electrical properties. In sharp 
contrast, around 70% of the double-transduced cells (12/17 cells from 5 different 
patients) analyzed in current-clamp mode responded with the generation of a single 
action potential upon depolarizing current injection, which could be blocked by the 
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sodium channel antagonist tetrodotoxin (TTX) (Figure 2.23). In addition, in voltage-
clamp these cells exhibited mode a clearly recognizable sodium current (Figure 2.23). 
These observations undoubtedly reveal a functional neuronal phenotype induced by the 
combined action of Mash1 and Sox2. However, the high input resistances as well as low 
action potential and peak sodium current amplitudes reflect the presence of low number 
of ion channels at the neuron´s membrane and therefore immature neuronal properties, 
even at prolonged time in culture (Figure 3.2). Considering the requirement of 
environmental cues in addition to the intrinsic mechanisms to promote maturation of 
neurons, it was hypothesized that cell-cell contact mechanisms and the action of soluble 
factors secreted from neighboring neurons might stimulate differentiation/maturation, 
creating more suitable physiological conditions. To test this possibility, human 
Mash1/Sox2-induced neurons were co-cultured together with neurons from mouse 
embryonic (E14) cerebral cortex. Under this conditions, an obvious increase in 
morphological complexity could be observed among the human neurons (Figure 2.24) 
but more importantly, they acquired the ability to fire chains of action potentials, adding 
further evidence for a neuronal identity as only functional neurons are capable of 
generating such a response upon current injection (Figure 2.24). Importantly, these 
induced human neurons were found to receive functional glutamatergic inputs from the 
co-cultured mouse embryonic neurons, as spontaneous synaptic activity could be 
detected (Figure 2.24). The glutamatergic identity of these synapses could be revealed 
by treatment with the α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid 
(AMPA)/ kainate receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), 
which blocks glutamate-mediated synaptic transmission 
230
 (Figure 2.24). These 
findings demonstrate that Mash1/Sox2-induced human neurons are indeed functional as 
they express transmitter receptors, are capable of assembling a postsynaptic 
compartment and can be recognized by other neurons as functional targets. In order to 
confirm the physical interaction between human and mouse embryonic neurons, 
immunocytochemical analysis for the expression of the vesicular glutamate transporter 1 
(VGlut1), typically found at the presynaptic terminals of glutamatergic neurons 
231
, was 
performed. Consistent with a functional glutamatergic input, the surface of dendrites of 
the Mash1/Sox2-induced human neurons were found to be decorated with Vglut1-
positive puncta, indicative of physical cell-cell contacts from surrounding glutamatergic 
neurons (Figure 2.24). In sum, these data demonstrates that neurons generated upon 
transduction of adult human brain perivascular cells with Mash1 and Sox2 and co-
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cultured with embryonic neurons acquire properties of functional neurons such as 
repetitive action potential firing and the ability to integrate into neuronal networks. 
 
2.5. Direct evidence of neuronal conversion 
 
Despite the high frequency of PDGFRß-positive cells infected by the retroviral vectors, 
other cells types could also be targeted and converted to neurons upon expression of 
Mash1 and Sox2, creating confusion in regard to the cell type subjected to neuronal 
reprogramming. In one experiment, FACS analysis revealed that a proportion of 97% of 
cells expressing the PDGFRß were found in the culture dish, indicating that virtually all 
expanded cells had a perivascular origin (Figure 2.9). In this particular culture, the 
combined expression of Mash1 and Sox2 resulted in the generation of 47% cells 
expressing ßIII-tubulin, displaying 26% of them a convincing neuronal morphology 
(n=203 cells). This experiment strongly suggested that the PDGFRß-positive population 
was the origin of the neurons; however, in order to unequivocally confirm the 
perivascular origin of the reprogrammed cells neuronal conversion was monitored by 
live-imaging (Figure 2.25). First, cultured cells were sorted based on their surface 
expression of PDGFRß (Figure 2.25) and left to recover for a period of 48hours. After 
this time, cells were transduced with retroviral vectors encoding for Mash1 and Sox2, 
which allowed for visualization of the infected cells by fluorescence (Dsred and GFP, 
respectively), and subsequently imaged by time-lapse video microscopy (Figure 2.25). 
After 3 days, expression of the reporter genes became apparent and the fate conversion 
of the transduced cells could be then monitored. Phase contrast image acquisition was 
carried out every 5 minutes; however, due to fluorescence toxicity, a frequency of 7,5 
hours between every acquired fluorescence image was necessary to avoid cell death. 
Interestingly, PDGFRß-positive cells display high mobility in culture, a situation that 
reduced the rate of successful imaging as many of the cells disappeared from the field of 
view. One important piece of information in regard to any reprogramming process is the 
timing of acquisition of cell lineage-specific hallmarks.   
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Figure 2.25: Direct evidence of neuronal reprogramming by live-imaging of FACS-sorted PDGFRβ-
positive cells from cultures of the adult human cerebral cortex. A, Left panel: FACS plot depicting the 
isotype controls for the analysis of PDGFRβ- and CD34-expression in a culture derived from adult human 
cerebral cortex. Right panel: FACS plot depicting PDGFRβ- and CD34-positive as well as negative 
fractions. CD34-negative/PDGFRβ-positive cells were sorted. B, Live imaging of the conversion of a 
PDGFRβ FACS-sorted cell (blue arrow) into a neuron following co-expression of Sox2 and Mash1. 
Pictures show phase contrast and fluorescence (Mash1-IRES-DsRed and Sox2-IRES-GFP) images at 
different time points (Days-Hours:Minutes) during the reprogramming process. Note the change of the co-
transduced cell from a protoplasmic to neuron-like morphology. C, Depicted is the last recorded time 
point in phase contrast (LT) and the post-immunocytochemistry (Post IC) of the reprogrammed cell for 
GFP (green), DsRed  (red) and ßIII tubulin (white). 
 
 
For a period of 10 days, all double-transduced cells exhibited high mobility and as well 
as erratic changes in morphology, in all cases remaining protoplasmic. Importantly, at 
day eleven some analyzed reporter-positive cells adopted a stable polarized morphology. 
Within the next two days, the fate conversion reached a state in which the morphological 
features of a neuron were obvious, namely a small elliptic cell soma and long thin 
processes emerging from it (Figure 2.25). In addition, these cells adopted a stable 
behavior, displaying a reduced mobility and, in the example, extending two opposite 
processes. To confirm the neuronal identity of the reprogrammed cells, 
immunocytochemical detection of ßIII-tubulin after imaging was performed (Figure 
2.25).  
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Figure 2.26: FAC-sorted cells positive for both PDGFRß and CD146 give rise to neuronal cells upon 
forced expression of Mash1 and Sox2. A, FACS plot depicting CD34-expression in a culture derived 
from adult human cerebral cortex. B, The CD34-negative population was resorted based on the double 
expression of PDGFRß and CD146. C, Sorted cells were subjected to Mash1/Sox2 induced neuronal 
reprogramming. 5 Examples of neuronal cells from PDGFRß/CD146 double positive pericyte-derived 
cells; Mash1-IRES-Dsred (red), Sox2-IRES-GFP (green), ßIII-tubulin (white). DAPI (blue); Scale 
bars:100µm. 
 
 
 
 
While none of the Sox2-positive cells (n≥300 cells) expressed the neuronal marker, 7% 
of Mash1-only (n=88 cells) and 20% (n=366 cels) were immunoreactive, indicating 
similar reprogramming efficiencies as in unsorted cultures. No morphological 
characterization was carried out due to the relatively short differentiation period 
(fourteen days). Considering that at day fourteen some cells were still undergoing the 
acquisition a neuronal fate, this experiment suggests that the reprogramming process did 
not occur in a synchronous manner throughout the culture. Following the onset of 
reporter expression, none of the analyzed cells underwent cell division, providing strong 
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evidence for direct conversion from adult human non-neuronal somatic cells into 
pericyte-derived neurons. The use of time-lapse video microscopy demonstrates that 
FAC-sorted proliferative protoplasmic PDGFRß-positive cells isolated from the adult 
human brain undergo a dramatic change in morphology within a period of 14 days, 
adopting a neuronal phenotype upon the combined expression of Mash1 and Sox2.  To 
exclude that some cell populations expressing PDGFRß could belong to cell lineages 
other than of perivascular origin, FACSorting was performed based on the combined 
surface expression of PDGFRß and CD146 (Figure 2.26). In contrast to the previous 
approach, cells were expanded for a period of 14 days after sorting, followed by 
retroviral transduction and subsequent live monitoring. Importantly, many cells with 
neuronal morphology and expression of ßIII-tubulin could also be found in a similar 
period of time (Figure 2.26), adding further evidence for a pericyte origin of the neurons 
present in the culture dish, excluding preexisting neuronal cells. 
 
2.6. In vitro conversion of adult mouse brain pericytes 
 
With the purpose of corroborating the results obtained with adult human cells I 
examined the potential of perivascular cells isolated from the cerebral cortex of adult 
wild type mice to give rise to neurons upon Mash1/Sox2 co-expression, focusing on the 
origin of the reprogrammed cells. I proceeded to culture cells from gray matter of the 
adult murine cerebral cortex. Special care was taken to remove all traces of meninges, 
since potential fibroblast growth could interfere with culturing of perivascular cells. I 
processed the tissue by mechanical dissociation in a similar manner as I did for the 
human samples. Cellular clones arising from protoplasmic cells were detected earliest 
five days after plating. Typically, these clones are characterized by the presence of a 
sphere-like structure, composed by a variable number of cells, from which protoplasmic 
cells arise, consistent with the observations in adult human brain perivascular cultures 
(Figure 2.5). Indeed, immunocytochemical analysis revealed that the cells forming these 
clones may have a perivascular origin, since they expressed NG2 (Figure 2.28), a 
marker of pericytes in vivo (Figure 2.27). Although oligodendrocyte progenitor cells 
(OPC) also express NG2, this possible identity is unlikely due to the fact that OPC are 
stellated in vitro, bearing thin processes arising from a small cell soma, and not 
protoplasmic, as perivascular cells appear. 
65 
 Results 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.27: Pericyte localization in the adult cerebral mouse cortex. A-A’, NG2 (red) expression in 
microvessel-associated cells in the adult mouse cerebral cortex. B-B’’, Higher magnification. C-C’, 
PDGFRß (red) expression in microvessel-associated cells in the adult mouse cerebral cortex. D-D’’, 
Higher magnification. Microvessels were visualized by CD31 (green) immunoreactivity; DAPI (blue). 
Scale bars: 50µm. 
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Figure 2.28: Characterization of cultures from adult mouse gray matter containing pericyte-derived 
cells. A-A’’, NG2 immunoreactive cells plated at low density form clones (5, 7, 12 days after plating, 
respectively). B, C, D,  Protoplasmic cells display expression of pericyte markers 20 days after plating. B, 
NG2 (red). C, PDGFRß(red). D, CD146 (red). DAPI (blue); Scale bars:100µm.  
 
 
In a period of 2-3 weeks, a few clones generated large number of protoplasmic cells, 
displaying expression of pericyte markers such as NG2 and CD146 (Figure 2.28); 
likewise PDGFRß (Figure 2.28), also expressed by pericytes within the brain (Figure 
2.27), was found to be expressed in cells arising from sphere-like structures (Figure 
2.28).  
These cultures were also analyzed by RT-PCR for the expression of several pericyte 
markers (Acta2/αSMA; Axl, receptor tyrosine kinase; Rgs5, regulator of G protein 
signaling 5 and PDGFRß) confirming the presence of perivascular cells within the 
culture dish (Figure 2.29). These protoplasmic cells were trypsinized and transduced 
with retroviral constructs (Figure 2.30), demonstrating their proliferative nature; 
however, mouse cells could not be passaged more than two times, in contrast to the 
ability of human cells to be passaged up to ten times. 
 
 
 
67 
 Results 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.29: Characterization of cultures from adult mouse cerebral cortex by RT-PCR. A, mRNA 
expression of mRNA for several pericyte markers in cultures from gray matter (GM) of the cerebral cortex 
of postnatal P5, late postnatal P20, and adult P60 mice was analyzed. For comparison, mRNA from brain 
and muscle isolated at postnatal stages P7 was used. B, Sox2 mRNA levels were analyzed in cultures from 
gray matter obtained at different developmental stages (P5, P7, P20 and P60). As positive control, 
cerebellar tissue from embryonic day E13,5 was used.   
 
 
I repeated the reprogramming approach applied to the human cells, namely to infect with 
retroviral contructs encoding for control (reporter gene DsRed/GFP), Sox2, Mash1 or 
Mash1/Sox2 in combination, to analyze for the expression of ßIII-tubulin and to 
distribute the reprogrammed cells into three morphological categories (a, flat; b, round; 
c, neuronal) (Figure 2.30). While control or Sox2-alone expressing cells did not up-
regulate ßIII-tubulin (Figure 2.30), 41% ± 10 SEM of Mash1-only cells displayed 
immunoreactivity for the neuronal marker, with a small proportion of them acquiring a 
neuronal morphology. Strikingly, combination of Mash1 and Sox2 gave rise to a 
significant increase in the proportion of ßIII-tubulin expression among double reporter-
positive cells to 92% ± 3 SEM. More importantly, the majority of them (72% ± 7 SEM) 
were identified as neurons by morphology (Figure 2.30).  
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Figure 2.30: Induction of a neuronal phenotype following co-expression of Sox2 and Mash1 in cell 
cultures from the adult mouse cerebral cortex. A, Cells transduced with a control retroviral construct 
expressing DsRed do not undergo morphological changes, remaining flat and polygonal. B-B’, In sharp 
contrast, a Mash1 (CAG-Mash1-IRES-DsRed) single-transduced cell (arrow) display a round morphology 
with a short process. Mash1 and Sox2 (CAG-Sox2-IRES-GFP) double-transduction results in the 
generation of a neuronal morphology, characterized by a round cell body and long branched processes; 
14DPI; Scale bar: 100μm. C-C’, Note that cells expressing Mash1 (red arrowheads) or Sox2 (green 
arrowheads) only are devoid of βIII-tubulin (white). Mash1(Dsred), Sox2(GFP); Scale bar: 100 µm. D, 
Quantification of the effect on βIII-tubulin expression and morphology following DsRed, Sox2, Mash1 or 
combined Sox2 and Mash1 expression in cultures from adult mouse cerebral cortex. Cells were 
categorized for exhibiting a flat polygonal, round without processes, or neuronal morphology. Histogram 
depicts the percentage of βIII-tubulin-positive among the reporter-positive cells (n=4). Error bars are 
SEM. Control and Sox2-positive cells were analysed by counting >100 cells per experimental replicate, 
of which none were ßIII-tubulin immunoreactive. E, Example of action potential firing of a Sox2 and 
Mash1 co-transduced cell in response to current injection in current-clamp. 
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The formation of neurons by forced expression of Mash1 and Sox2 is more efficient in 
mouse cells compared to the results obtained from human cells, in regard to the 
proportion of responding cells as well as to their ability to acquire morphological 
hallmarks of neurons.  
In order to demonstrate that these cells were indeed neurons, electrophysiological 
recordings were performed. In current-clamp mode, step-current injection in 
Mash1/Sox2 induced-neuronal cells elicited action potential firing, evidencing their truly 
neuronal identity (Figure 2.30). The analyzed reprogrammed mouse neuronal cells 
displayed more mature electrophysiological properties as human cells did in a similar 
period of time, adding support for an ease in reprogramming of mouse cells (Figure 
2.30). Although neurons could be generated from adult mouse cortical cultures, the 
identity of the cells prior reprogramming had to be addressed. The use of mice allows 
for genetic fate mapping and since NG2 appeared to be expressed by these cells, I 
searched for a mouse line in which cells expressing NG2 could be labeled, allowing for 
detection and identification prior reprogramming. The knock-in strategy used to 
generate transgenic NG2-EYFP mice 
232
 allows for fluorescence labeling of NG2-
positive cells in vivo and also in culture (Figure 2.31). In fact, a large number of EYFP 
positive cells could be found in cultures from gray matter isolated from heterozygous 
NG2-EYFP mice. 
 
 
Figure 2.31: Reporter positive cells isolated from the cerebral cortex of NG2:YFP mice can be 
cultured. YFP-positive cells (GFP green) are immunoreactive for NG2 (red); DAPI  (blue); 12 days in 
vitro.  
 
 
However, due to the control of reporter expression by the NG2 promoter, labeling of 
NG2-positive cells was transient and progressive loss of fluorescence intensity 
throughout the culturing period took place, indicating that the expression of NG2 
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fluctuates in vitro. Although the use of this mouse line confirmed that a large proportion 
of the cells could indeed be of perivascular origin, no stable fate mapping could be 
achieved to demonstrate that the generated neurons were originally NG2-positive cells. 
In addition, as other cell types express this marker, no definitive proof for a pericyte 
identity could be provided using this transgenic knock-in mouse line. To unequivocally 
determine the origin of the reprogrammed cells from pericytes I took advantage of a 
transgenic mouse line which expresses an inducible Cre recombinase (CreERT2) under 
the control of the tissue non-specific alkaline phosphatase (TN-AP) promoter 
233
.  
 
 
 
Figure 2.32: Specific expression of β-galactosidase in microvessel-associated pericytes in the cortex 
of Tg:TN-AP-CreERT2:R26R
NZG 
mice. Specific β-galactosidase expression associated with CD31-
positive blood vessels in the cerebral cortex of Tg:TN-AP-CreERT2:R26R
NZG
 mice. A, ß-Galactosidase-
positive cells express the pericyte marker PDGFRß. Note the restricted expression around microvessels. β-
 10 µm.  B, 
β-Galactosidase-positive cells lining microvessels express NG2. Note a NG2-positive, β-galactosidase-
negative cell that is not associated with a microvessel (white arrowhead). β-galactosidase (green), NG2 
(red), DAPI (blue). Scale bars: left panel 50 µm, right panels 10 µm. Sagittal sections of cortical tissue 
(postnatal day 30) were analyzed for the expression of β- C, 
Overview showing β-galactosidase (green), PDGFRß (red) and CD31 (blue) expression. Note the 
restricted expression of β-galactosidase and PDGFRß (red) associated to blood vessels. D, Overview 
showing β-galactosidase (green) and NG2 (red) expression. Note co-expression of β-galactosidase and 
NG2 in cells associated with blood vessels. DAPI (blue). Scale bars: left panels 100μm, right panels 
50μm. 
 
 
Originally, the TN-AP:CreERT2 mouse line has been used to label pericytes in skeletal 
muscle since alkaline phosphatase (AP) expression can be detected in vessel-associated 
cells at juvenile and adult stages in this tissue 
233
. AP expression is not restricted to 
skeletal muscle and can be found widespread in intestine, bone and liver 
234
. Three 
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isoforms of AP have been identified in mouse: placental, intestinal and tissue-
nonspecific AP, with only the latter being exclusively expressed in skeletal muscle 
233
; 
however, no information regarding the specific labeling of pericytes in the brain by AP 
was available. TN-AP-CreERT2 mice were crossed to R26R reporter lines to identify 
cells by expression of a nuclear form of ß-Galactosidase (ß-Gal) for in vivo analysis 
(TN-AP-CreERT2:R26
NZG
) or enhanced yellow fluorescent protein (EYFP)  for in vitro 
reprogramming experiments (TN-AP-CreERT2:R26
EYFP
) following postnatal tamoxifen-
induced Cre-mediated excision of the stop cassette allowing expression of the reporter 
gene. I first examined the specificity of recombination in the cerebral cortex of these 
mice at late postnatal stages (P25) by immunofluorescence and confocal microscopy 
(Figure 2.32). As pericytes are vessel-associated cells, I used antibodies against CD31 
235
 to label endothelial cells forming the blood vessels for anatomical localization of 
perivascular cells. The TN-AP-CreERT2:R26
NZG 
mice were analyzed for the expression 
of ß-Galactosidase, readily and exclusively detectable along blood vessels throughout 
the cerebral cortex (Figure 2.32). As expected, the signal corresponding to ß-
Galactosidase (ß-Gal) was confined to the soma of the reporter positive cells (Figure 
2.32), adding further evidence for a specific expression profile. Confocal analysis of the 
brain sections showed that these ß-Gal positive cells were lining CD31-positive vessels, 
being negative for CD31 expression and therefore excluding that they were endothelial 
cells (Figure 2.32). To further demonstrate that these reporter-positive cells were indeed 
pericytes, I performed co-localization analyses using markers of pericytes such as 
PDGFRß and NG2. As expected, ß-Galactosidase expression co-localized with both 
PDGFRß, which is exclusively expressed by pericytes in the brain, and NG2 confirming 
that TN-AP promoter activity allows for reliable genetic fate mapping of pericytes in the 
cerebral cortex of mice TN-AP-CreERT2 (Figure 2.32). Of note, NG2 cells not located 
at perivascular positions (presumably OPCs) were negative for the expression of ß-Gal, 
and so excluding labeling of cells of non pericytic origin (Figure 2.32).  
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Figure 2.33: In vitro conversion of fate-mapped adult mouse brain pericyte-derived cells into 
neurons. A, B, Fate-mapped pericyte-derived cells isolated from mice Tg:TN-AP-CreERT2:R26R
EYFP
 
can be expanded in vitro. A, Upon tissue dissociation, cells were directly plated on PDL-coated coverslips 
and analyzed 5 days later for the expression of EYFP (green), PDGFRß (red), NG2 (red) and CD146 
(red). Single cells or small clones of EYFP (green) positive cells co-express pericyte markers. B, Large 
clone of EYFP-positive (green) fate-mapped cells following direct plating at low density demonstrating 
substantial clonal expansion in vitro; 20DIV. DAPI (blue). Scale bars: C, 50 μm, D,100 μm. C-C’, 
EYFP-positive cells (green) isolated from the cerebral cortex of adult Tg:TN-AP-CreERT2:R26R
EYFP
 
mice transduced with a control vector (red). Note the lack of ß-tubulin immunoreactivity (white); 14DPI. 
Scale bar: 100 µm. d-d’, Reprogramming of EYFP-positive cells isolated from the cerebral cortex of 
adult Tg:TN-AP-CreERT2:R26R
EYFP
 mice into neurons.  EYFP-positive cells (green) transduced with 
Mash1 (red) and Sox2 (without reporter) display a neuronal morphology and express ßIII-tubulin; 14 DPI. 
Scale bar: 100 µm.  
 
Next, I prepared cultures from the adult cerebral cortex of TN-AP-CreERT2:R26
EYFP 
mice under the same conditions as used with wild type mice samples. I plated the cells at 
low density to observe the formation of clones and performed immunocytochemical 
analyses at different time points for the expression of EYFP. After 5 days in culture, 
reporter positive cells could be found as single cell or in small clones, positive for the 
expression of the pericyte markers PDGFRß, NG2 and CD146 (Figure 2.33). After 20 
days, clones containing large number of reporter-positive protoplasmic cells could be 
easily detected, demonstrating that pericyte-derived cells could be expanded in vitro 
(Figure 2.33). In order to confirm their ability to proliferate, I infected EYFP-positive 
cells with retrovirus encoding for DsRed (control), with a majority of the pericyte-
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derived cells being positive for the retroviral reporter gene expression and thus 
demonstrating that pericytes can be expanded and targeted with retroviral constructs in 
vitro (Figure 2.33). To investigate whether these EYFP-positive pericyte-derived cells 
can be reprogrammed to neurons, I used retroviral constructs encoding for Mash1 
together with Dsred and Sox2 without reporter to allow visualization of potentially 
generated EYFP-positive neurons, indicating a pericyte origin. While no changes 
occurred upon control vector transduction, the generation of ßIII-tubulin positive 
pericyte-derived neurons in Mash1 and Sox2 transduced cultures could be observed 
(Figure 2.33), corroborating that cells of pericytic origin can undergo neuronal 
conversion by the combined activity of Mash1 and Sox2.  
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3.  DISCUSSION 
 
3.1. Summary 
 
In this study I provide compelling evidence for the feasibility of a direct conversion 
approach to reprogram somatic cells from the adult human cerebral cortex into 
functional neurons in vitro by forced expression of neurogenic transcription factors. 
Somatic cells could be isolated from adult human brain tissue and subsequently cultured 
and expanded in adherent conditions. Characterization of these cell cultures by 
immunocytochemistry, qRT-PCR and FACsorting revealed the enrichment of a cell type 
which shares marker expression with perivascular cells in vivo. Although the expression 
levels vary upon culturing and the presence of other cell types such as fibroblasts, 
endothelial cells, etc. cannot be excluded, the vast majority of the proliferative cells 
resemble perivascular cells based on their molecular expression profile. Notably, gene 
expression analysis excluded the presence of neural progenitor and stem cells. Under 
standard culturing methods, barely any astroglial cells were observed in culture. In 
contrast, applying milder dissociation conditions allows the isolation of astroglial cells, 
which in vitro did not have the ability to proliferate and die upon passaging. Retroviral 
vectors are limited in their use as they only target dividing cells. However most of the 
cells in culture were mitotically active and, therefore, a high proportion of them were 
transduced with retroviruses encoding neurogenic transcription factors. Among all tested 
factors, only the combination of Mash1 and Sox2 resulted in the direct conversion of 
adult human perivascular cells isolated from the cerebral cortex into functional neurons. 
The identity of the pericyte-derived cells was assessed by immunocytochemistry, 
showing expression of markers of mature neurons (MAP2 and NeuN), as well as 
neuronal subtype specific molecules (GABA and Calretinin). Importantly, the electrical 
properties of the neuron-like cells were assessed by patch-clamp recordings, revealing 
the ability of these cells to fire action potentials and receive synaptic inputs from 
embryonic mouse neurons. In order to exclude the presence of pre-existing neurons and 
to monitor the neuronal conversion, cultured human perivascular cells were sorted based 
on the surface expression of PDGFRß, typically labeling brain perivascular cells in vivo, 
and subsequently transduced with Mash1 and Sox2. Double-positive cells were followed 
by means of time-lapse video microscopy for a period of 14 days demonstrating the 
transition from protoplasmic to neuronal cell. To corroborate the feasibility of a direct 
pericyte-to-neuron conversion, a transgenic mouse line was used in which brain 
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pericytes could be labeled in vivo prior to culturing. Following the same procedure as 
with human brain material, fate-mapped pericytes could be expanded and reprogrammed 
to a neuronal phenotype by combination of Mash1 and Sox2, thus confirming the 
neurogenic potential of perivascular cells isolated from the cerebral cortex of adult 
mammals.   
 
3.2. Are pericytes stem cells?  
 
When aiming at the development of cell-based replacement strategies, it is worthwhile 
targeting  a cell type which displays a high degree of plasticity (differentiation into other 
cell types) as well as the potential to resume proliferation upon tissue damage (to replace 
lost cells). The adult mammalian brain contains two regions of neurogenesis which 
could serve as a source of new neurons 
236
. However, great number of replacing neurons 
would be necessary as well as approaches to induce targeted migration to the spot of 
injury or disease 
237
. Alternatively, cell types found at the site of neurodegeneration (e.g. 
astrocytes, microglia, OPCs, endothelial and perivascular cells) could be amenable for 
direct conversion. First, some of them such as astrocytes and perivascular cells are 
developmentally related to neurons, as they share an ectodermal origin 
84,217
. In addition, 
stem cell properties have been reported regarding astrocytes and perivascular cells, 
indicating their potential to differentiate into other cell types 
84,214
. One advantage of this 
approach is that there is no need for migration since they are located at the site of 
disease. In particular, brain perivascular cells are excellent candidates for a direct 
conversion approach as their counterparts in other organs display stem cell potential, 
which is discussed below. 
The hematopoietic stem cell (HSC) system is so far the best characterized tissue-specific 
stem cell population with all blood cell components being derived from a subset of bone 
marrow (BM) residing stem cells 
238
. The HSC system importantly contributed to the 
definition of the term “stem cell”, a cell type which is characterized by their ability to 
differentiate into different mature cell lineages (multipotency) and to self-renew in order 
to replenish the stem cell pool 
239
. The finding that bone marrow stromal cells can 
generate bone, cartilage, fat and reticular cells suggested the presence of BM multipotent 
precursor cells with broad differentiation potential 
240,241
. Further experiments showed 
that these precursor cells were fibroblast-like cells selected by adherence to plastic 
surfaces and with the ability to proliferate in vitro and, therefore, termed colony-forming 
unit fibroblasts (CFU-Fs) 
240
. In vitro, cells derived from single CFU-Fs retain their 
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ability to differentiate into osteoblasts, chondrocytes and adipocytes and became 
designated as “mesenchymal stem cells” (MSCs) 
242
 referring to in vivo precursors and 
their in vitro-expanded progeny. Latest attempts to redefine the nomenclature have led 
to the use of “mesenchymal stromal cell” for the in vitro cultured cells 
243,244
. Beyond 
their in vitro properties 
245
, mesenchymal stromal cells have the ability to differentiate in 
vivo into cartilage and bone when transplanted in mice 
246,247
. Moreover, the 
differentiation of diverse cell types of mesodermal and non-mesodermal origin such as 
endothelial cells 
248
, cardiomyocytes 
249
, and hepatocytes 
250
 has been reported from 
mesenchymal stromal cells, however, accompanied by controversy due to a lack of 
standard methods for isolation, expansion and identification 
206
. Indeed, heterogeneity 
can be observed in mesenchymal stromal cell cultures as assessed by differences in 
morphology, proliferative capacity and in vitro and in vivo differentiation potential 
251-
254
. Additional studies have shown that stromal cells derived from postnatal and 
embryonic tissues give rise to cultures with diverse morphologies, differentiation 
potential and gene expression profiles, suggesting the absence of a biological equivalent 
among mesenchymal stromal cells from different anatomical locations 
255-257
.  
Immunophenotype analyses of mesenchymal stromal cell cultures have revealed a panel 
of human cell surface markers expressed such as CD73, CD90 and CD105, with 
endothelial and hematopoietic cell markers being absent 
238
; however, their expression 
varies depending on the isolation methods and passage 
244
. The identification of CD146 
as a marker for perivascular self-renewing progenitors located surrounding microvessels 
in the bone marrow has contributed to the in vivo characterization of MSCs 
258
. Due to 
their in vivo perivascular location, morphology and similar cell surface antigen profile 
when cultured, an association has been proposed for pericytes and MSCs 
259,260
. In 
addition, pericyte-derived cultures have been shown to differentiate into chondrocytes, 
adipocytes, osteoblasts as well as smooth muscle cells and myocytes 
261-263
. 
Furthermore, recent work has identified a combination of markers such as PDGFRß, 
NG2 and CD146 specifically labeling pericytes in diverse human organs of human fetal 
and adult origin 
205
. Cultures derived from directly isolated human pericytes displayed 
osteogenic, chondrogenic and adipogenic potential in vitro as well as osteogenic 
potential in vivo 
205
. Although a relationship between pericytes and MSCs has been 
suggested, it is worthwhile mentioning that the term pericyte refers exclusively to cells 
at perivascular locations around capillaries and post-capillary venules 
259
 and that MSC-
like cells have been isolated from the walls of arteries and veins 
264,265
. Thus, it can be 
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concluded that not all MSCs can be defined as pericytes and not all pericytes display 
properties of MSCs 
206
.   
Considering the potential of perivascular cells to differentiate into other cell types and 
the data provided in this thesis demonstrating the feasibility of converting brain 
perivascular cells into induced neuron-like cells, it is likely that perivascular cells 
outside the CNS might respond similarly to the combined expression of Mash1 and 
Sox2. This is relevant when using human cells from easily accessible tissues in order to 
generate personalized in vitro disease models from patients with neurological diseases, 
avoiding the use of brain tissue biopsies. Recent observations from other groups support 
the idea that cells from organs outside the CNS (such as skin fibroblasts and 
hepatocytes) may serve as a substrate for direct neuronal conversions. 
 
3.3. Fibroblast to neuron direct conversion 
 
In this study I have shown data demonstrating the feasibility of the in vitro direct 
neuronal conversion of non-neural somatic cells of adult human origin following 
retrovirally-mediated expression of neurogenic transcription factors. Other groups have 
shown that cells from non-related cell lineages (such as skin fibroblasts and hepatocytes) 
can be directly converted into neurons by the combined activity of several 
reprogramming factors such as transcription factors and microRNAs, corroborating the 
approach of direct conversion of adult non-neural-to-neural cell through the addition of 
exogenous factors shown in this thesis. 
In order to the test the feasibility of neuronal direct conversion from distant cell 
lineages, Wernig and colleagues 
266
 selected a pool of transcription factors involved in 
neural lineage specification to screen for factors which could induce neurogenesis. 
Alone or in random combinations, these transcription factors were over-expressed in 
embryonic mouse fibroblasts; Mash1 itself (also known as Ascl1) was shown to instruct 
an immature neuronal phenotype. The authors identified a pool of three transcription 
factors sufficient to instruct functional neuronal identity, namely Mash1, Brn2 and 
Myelin transcription factor 1-like (Myt1l), (ABM), as assessed by the ability of these 
induced neurons to fire repetitive action potentials and to form synaptic contacts with 
mouse embryonic cortical neurons 
266
. 
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Figure 3.1: Direct conversion approaches. 
 
 
Despite the fact that Mash1 specifies GABAergic interneurons during cortical 
development 
135
, when co-cultured with primary astrocytes, ABM expressing neurons 
adopted an excitatory glutamatergic phenotype. Brn2 is expressed in the developing 
mouse ventral telencephalon and spinal cord, co-localizing with the expression of 
Mash1 in the ventricular and subventricular regions. Together they synergistically 
regulate transcription of Delta1, a component of the notch signaling pathway and 
cooperatively regulate neuronal differentiation 
153
. Brn2 is also expressed in progenitors 
which give rise to glutamatergic cortical neurons located in layers II/III and V 
267
. Myt1l 
is a CCHC domain-containing zinc finger transcription factor expressed by 
differentiating neurons in both the central and peripheral nervous system 
268,269
. In the 
following, various groups have shown that functional neurons can be generated from 
human fibroblasts. One approach takes advantage of the ABM combination to convert 
fetal and postnatal human fibroblasts to neurons, but requires the addition of the basic 
helix-loop-helix NEUROD1 to facilitate neuronal conversion
270
. Interestingly, the 
expression of the microRNAs miR-9* and miR124 are sufficient to generate cells with 
immature neuronal morphologies in human skin fibroblast cultures while in 
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combination with ASCl1,MYT1L and NEUROD2 induces the conversion to functional 
neurons 
271
. The microRNAs miR-9* and miR124 instruct compositional changes of 
SWItch/Sucrose NonFermentable (SWI/SNF)-like BAF chromatin-remodeling 
complexes, a process required during neuronal differentiation 
272
. In addition, other 
groups have focused on the generation of different types of neurons from human 
fibroblasts. The combination of the transcription factors Mash1, nur related protein 1 
(Nurr1) and LIM homeobox transcription factor 1 alpha (Lmx1a) 
273
 or Mash1, Brn2, 
Myt1l, Lmx1a and forkhead box A2 (FoxA2) 
274
 induces the formation of dopamine-
releasing tyrosine hydroxylase-positive neurons from mouse fibroblasts, however 
without the ability to form synapses. Furthermore, human neurons with a spinal motor 
phenotype could be generated, yet requiring the combination of 8 transcription factors 
275
. Of note, skin fibroblast isolated from familial Alzheimer disease patients could be 
converted to neuronal cells which exhibited some hallmarks of this pathology such as 
increased production of Aß peptide compared to neuronal cells generated from skin 
fibroblasts of healthy individuals 
276
. However, fibroblast cultures represent a 
heterogeneous mesenchymal progenitor cell population that may contain neural crest-
derived cells. A recent study has reported that terminally differentiated endodermal cells 
(i.e. hepatocytes) can be directly converted to neurons 
277
. 
Taken together, these reports support the feasibility of transcription factor-mediated 
direct neuronal conversion from different cell lineages and its potential application in 
human cell based-replacement strategies and disease modeling (Figure 3.1).     
 
3.4. Properties of directly converted neurons from adult brain 
perivascular cells 
 
In order to assess the extent of neuronal reprogramming from adult perivascular cells it 
is necessary to establish some criteria, which could be equivalent to those applied to 
neurons generated in vitro upon differentiation of neural or embryonic stem cells 
278-280
. 
Despite a great heterogeneity among neurons present in the nervous system, some 
common features can be defined 
281
:  
1, a neuron is polarized and extends one main process (axon) and several dendrites from 
an elliptic/round soma; the expression of proteins such as the nuclear epitope NeuN, 
restricted to the nucleus of newly generated neurons, or specific cytoskeletal proteins 
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such as the microtubule-associated protein MAP2, in dendrites, provides information in 
regard to the neuronal identity (Figure 3.2).  
2, neurons display characteristic membrane properties conferred by the presence of 
voltage-gated and transmitter–dependent ion channels; the ability of a neuron to fire 
action potentials relies on the orchestrated action of these proteins. As an immature 
neuron differentiates, the resting potential becomes hyperpolarized (-50mV to -70mV) 
(Figure 3.2) and the capacitance increases, proportional to the increase in cell surface 
area. As more membrane channel proteins are expressed during neuronal differentiation, 
the input resistance of a neuron´s membrane decreases (Figure 3.2). Also the action 
potential amplitudes increase as a neuron matures (Figure 3.2). A mature action 
potential is characterized by a constant amplitude, with fast depolarization and fast 
repolarization; the latter is responsible for the rapid regeneration of voltage-gated Na+ 
channels allowing the characteristic firing of trains of action potentials (Figures 2.24, 
3.2) in mature neurons 
282,283
. Experimentally, action potential firing can be evoked by 
injecting currents in the neuron (Figure 3.2). 
3, neurons have the ability to form synapses, structures that neurons use to contact to 
each other and where neurotransmitter release occurs with high temporal and spatial 
precision. While almost all neurons generate synaptic outputs (except for 
neuromodulatory neurons), some do not receive synaptic inputs (e.g. primary sensory 
neurons). A fully functional neuron has the competence to establish synaptic inputs to 
other neurons. Synapse formation can be revealed by the presence of presynaptic 
vesicular structures in close proximity to MAP2 positive dendrites (Figure 2.24). By 
recording spontaneous synaptic currents, the synaptic activity can be unambiguously 
proved, as this technique can reveal the process of exocytosis and the postsynaptic 
response in form of sharp rise and slow decay phases (Figure 2.24). When neurons are 
exposed to specific neurotransmitter blockers, the synaptic activity can be definitively 
demonstrated; it also allows the distinction between excitatory and inhibitory responses 
(Figure 2.24). Furthermore, the presence of soluble glial factors and input from 
neighboring neurons is required for maturation and formation of functional synapses 
(Figure 2.24) 
284,285
.  
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Figure 3.2: Comparison of electrophysiological properties of neurons following co-expression of 
Mash1-Sox2 in human and mouse perivascular cells culture. 
 
 
3.5. Synergism between Mash1 and Sox2 
 
I have shown that the expression of Mash1 or Sox2 alone does not result in the 
formation of neuron-like cells when expressed in perivascular cells from the adult 
human brain (Figure 2.21). In sharp contrast, the co-expression of Mash1 and Sox2 
leads to the generation of functional neuron-like cells, suggesting a synergism between 
these transcription factors (Figure 2.19, 2.24).   
The bHLH transcription factor Mash1 (and neurogenins) promotes cell cycle exit, inhibit 
differentiation of neighboring progenitors through Notch signaling-mediated lateral 
inhibition and drives both neuronal differentiation and subtype specification 
137
. bHLH 
transcription factors form heterodimers with bHLH proteins encoded by the E2A gene, 
and bind to subtype- and tissue-specific hexa-nucleotide motifs (E-box) present in the 
promoter of target genes 
137,286
. Additional interactions between DNA-binding proteins 
are required for specificity of target gene recognition. One example of cooperative 
interaction during vertebrate neurogenesis involves the synergistic activation of the 
motor neuron determination gene Hb9 by interaction of the bHLH protein NeuroM and 
the LIM-homeodomain transcription factors Islet1 and Lhx3 
287
. Interestingly, a 
mechanism of synergistic cooperation for Mash1 has been proposed 
153
. Mash1 regulates 
the expression of the Notch ligand Delta1 in differentiating neurons, resulting in the 
activation of Notch signaling in a subset of neural progenitors and thereby promoting 
maintenance of an undifferentiated state 
153
. This study revealed the synergistic activity 
through cooperative binding to a conserved motif of the Delta1 gene by Mash1 and 
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POU3F2, a member of the class III POU family of homeodomain proteins (also Brn2). 
Further analysis demonstrated the role of Brn proteins in cell cycle exit, initiation of 
neuronal differentiation and radial migration of neurons 
153
 highlighting the critical roles 
of DNA-binding cofactors during neural vertebrate development. 
During Drosophila embryogenesis, CNS midline neurons and glia provide signals for 
differentiation of neighboring neuroectodermal and mesodermal cells 
288
. The epidermal 
growth factor (EGF)-repeat protein Slit is highly expressed in midline glial cells and 
prevents commissural axons from re-crossing the midline 
289
. The bHLH transcription 
factor single minded (Sim), the Sox HMG domain protein Fish-hook (Fish) and the POU 
protein drifter (Dfr) regulate Slit transcription by directly interacting to each other on the 
promoter of the Slit gene and so regulating CNS midline development and gene 
expression 
290
. This study demonstrates the physical interaction of bHLH proteins 
together with HMG-Sox domain proteins and identifies a synergistic cooperative 
mechanism of gene expression involving these families of transcription factors. 
All together, these findings support the idea of synergistic control of gene expression by 
the bHLH  protein Mash1 and the HMG domain-containing protein Sox2, and offers a 
likely explanation for the generation of neurons following forced expression of Mash1 
and Sox2 in adult human perivascular cells.   
 
3.6. The role of Sox2 in neuronal differentiation and GABAergic 
specification  
 
I have shown that forced co-expression of the neurogenic transcription factors Mash1 
and Sox2 in perivascular cultures from adult human cortex results in the formation of 
neurons immunoreactive for GABA and, to a lower extent, Calretinin (Figure 2.24).  
Over-expression experiments in chick embryo neural tube have shown that increased 
Sox2 levels prevents neuronal differentiation of neural progenitors into ßIII-tubulin 
positive neurons, reinforcing their self-renewal 
116
. Additional experiments in embryonic 
neural precursors in vitro led to similar results indicating a direct correlation between 
Sox2 expression and inhibition of neurogenesis 
212
. 
The in vivo expression of Sox2 in subsets of differentiated cortical neurons at early 
postnatal stages has been reported 
121
, suggesting a role for Sox2 beyond neural stem 
cell/precursor cells maintenance 
115
. By means of a Sox2 enhancer deletion, Cavallaro et 
al. 
291
 have suggested a novel function for Sox2 in neuronal differentiation and 
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specification.  Heterozygous Sox2-deficient mice display a reduction in Sox2 expression 
by about 70% and exhibit neural stem/precursor cell proliferative defects in the 
hippocampus and periventricular zone 
121
. In vitro, embryonic Sox2-deficient neural 
stem cells display differentiation defects, assessed by the abnormal morphology and 
reduced expression of mature neuronal markers, suggesting a role of Sox2 in neuronal 
differentiation. Rescue experiments in which Sox2 lentiviral delivery was performed at 
the onset of neuronal differentiation resulted in normal arborized MAP2-positive 
phenotype in mutant cells 
291
. Interestingly, late expression of Sox2 did not rescue the 
mutant phenotype, indicating an early role of Sox2 in neuronal differentiation. 
Additionally, mutant cells showed expression of ßIII-tubulin and GFAP simultaneously. 
By co-transfection of a GFAP promoter-driven reporter transgene, a direct repressor 
activity of Sox2 could be demonstrated since following Sox2 over-expression reporter 
activity was inhibited 
291
. In vivo analysis revealed abnormalities in subset of neurons. 
Cavallaro et al. reported a decrease by 40-60% in the number of GABAergic cells in the 
cortex and the olfactory bulb of Sox2-deficient mice at P0. The authors found migration 
defects in GABAergic neurons from the ganglionic eminences during embryonic stages 
to the cortex as well as abnormalities in neuronal morphology in the early postnatal 
cortex; also the olfactory bulb displayed a slight reduction in the number in Calretinin-
positive neurons at early postnatal stages 
291
. In summary, the authors concluded that in 
vivo only a subpopulation of GABAergic neurons in the Sox2-deficient mice is affected 
by the reduction in the levels of Sox2.  
Together with the role of Mash1 in GABAergic neuronal specification, the data of 
Cavallaro et al. 
291
 supports the finding of GABA- and Calretinin-positive neuronal cell 
generation following forced co-expression of Sox2 and Mash1 in perivascular cells from 
the adult cerebral cortex (Figure 2.21). 
A precise quantitative expression profile plays a major role in the activity of Sox2 and 
other transcription factors 
127
. Moreover, as Sox2 plays a role in early differentiation, it 
is possible that constitutive expression of Sox2 may inhibit neuronal maturation. For this 
reason, an approach to time-dependently reduce the levels of exogenous Sox2 by 
generation of microRNAs against the Sox2 cDNA encoded in a lentiviral construct was 
designed (Figure 3.3).  
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Figure 3.3: MicroRNA-mediated Sox2 
down-regulation in HEK cells. Western 
blot analysis shows 4 different microRNAs 
agains Sox2 (1-4). As loading control, 
gamma-tubulin was analyzed; C-: negative 
control. 
 
 
It remains open whether a Sox2 down-regulation approach results in further maturation 
of Mash1/Sox2-induced neurons from adult perivascular brain cells.         
 
3.7. Astroglia and pericytes in cell-based replacement strategies 
 
Both astroglia and pericytes have been shown to resume proliferation upon acute CNS 
injury 
5,203
. After acute brain lesion, adult astroglia express markers only found in 
subventricular and hippocampal astroglia-like stem cells in the healthy brain 
5,84
. The 
acquisition of stem cell properties are revealed by the ability of astrocytes to resume 
proliferation in vivo and to form self-renewing and multipotent neurospheres in vitro 
e.g. after stab wound injury or stroke 
5,84
. Following acute stab wound injury, the 
astrocyte cortical population doubles in number within the first 2 weeks, with a peak of 
proliferation three to seven days after injury, and returns to baseline levels two weeks 
after injury 
213
. Some of these newly generated astrocytes also take part in the formation 
of the glial scar following CNS injury. Over-expression of neurogenic factors or 
blockage of gliogenic cues in astroglia, resulted in the appearance of neuroblasts in 
nearby locations at the lesion, suggesting a role for astrocytes as a candidate cell type 
for cell-based repair purposes after brain injury
292
.  
Interestingly, also pericytes have been shown to react and resume proliferation in 
response to CNS lesion. After contusive spinal cord injury, pericyte reaction follows a 
similar time line as shown for astrocytes. At day one and two after injury, the core 
lesion area is largely devoid of blood vessels. Within three and five days after injury, 
blood vessel sprout paralleled by an increased density of associated pericytes, which 
appear at the lesion site 
203
. Göritz et al. demonstrated that the increase in pericyte 
number is indeed due to a reactivation of proliferation following spinal cord injury and 
not due to migration from unaffected spinal cord regions 
203
. The number of pericyte-
derived cells reached a peak two weeks after spinal cord injury. Notably, two weeks 
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after a lesion, there are about two times more pericyte-derived cells as newly generated 
astrocytes in an injured spinal cord segment 
203
.  
Therefore, the ability of astroglia and pericytes to resume proliferation following CNS 
acute injury supports the development of in situ reprogramming approaches; 
considering the increase in cell number, potential direct conversion strategies may rely 
on proliferating astroglia and/or pericytes to replace neuronal cells which are 
permanently lost upon injury or disease.  
Epilepsy is one neurological disorder which could be treated by a cell-based 
replacement strategy. The most common form of human epilepsy is the mesial temporal 
lobe epilepsy (MTLE) which is characterized by epileptogenic abnormalities in mesial 
temporal structures where neural loss and reorganization takes places 
293
. This type of 
epilepsy is associated with cognitive impairment and pharmacoresistance; it is not 
known what precise cell type causes the network imbalance or generates seizure 
discharges 
293
. Surgical selective resection of medial temporal structures, including the 
amygdala and the hippocampus, results in effective relief of the symptoms, indicating 
that these are brain regions are involved in most cases of MTLE 
293
. The onset of 
epilepsy is preceded by a phase of epileptogenesis, causing alterations in neuronal 
structure and function; the disease proceeds with the spontaneous generation of seizures 
in the affected regions 
293
. Some hypothesis have been proposed to explain the initiation 
of focal seizures; in the hippocampus, mossy fibers redirect their axonal output to each 
other, creating a recurrent excitatory network; alternatively, it has been observed that 
hippocampal hyperinhibition collapses before a seizure, allowing the generation of 
granule cell discharges through hyperexcitablity 
293
. Therapeutical strategies might 
focus on modifying the neuronal circuitry to inhibit the hyperexcitable neurons. 
Electrical activity remains abnormal within the epileptic focus by afterpolarization, a 
process which in normal conditions is dependent on feedback inhibition by inhibitory 
interneurons 
293
. Distortion of this network impairs neuronal membrane repolarization 
and causes the generation of synchronous high-frequency action potentials
 293
. By 
formation of new inhibitory synaptic contacts, hyperexcitation-driven discharges could 
be abolished.  
One transplantation approach has shown functional integration of medial ganglionic 
eminence (MGE)-derived GABAergic interneurons in the cortex and hippocampus of 
juvenile mouse; by electrophysiological recordings it was shown that the MGE-derived 
grafted cells adopted mature neuronal phenotypes as well as modified the activity of the 
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host brain 
293
. In order to compensate the hyper-excitatory neuronal activity, one 
possible strategy would be the generation of inhibitory GABA-ergic neurons by 
expression of Mash1 and Sox2 in adjacent glial or perivascular cells, thereby creating a 
balanced electrical network. An emerging concern of this strategy is the low efficiency 
of survival and integration of newly generated neurons in adult diseased tissue. 
Additional studies regarding the requirement of soluble factors (i.e. neurotrophins) to 
modulate the environment are essential to advance in the development of cell-based 
strategies in adult CNS tissue.  
 
3.8. Induced pluripotency versus direct conversion strategies 
 
Both approaches represent complementary methods to better understand pathologies and 
to design strategies for regenerative medicine; in particular, the lack of human neurons 
for experimental purposes accounts for one of the reasons of the limited available 
knowledge about most of human brain disorders.  
Reprogramming of somatic cells to an induced pluripotent state has the advantage of 
unlimited growth, allowing the performance of high throughput assays (e.g. multiple 
drug testing assays) but the process is long and laborious 
30
; in addition, generating 
patient-specific induced pluripotent cells (iPS) from numerous individuals is an arduous 
challenge. Furthermore, the differentiation of iPS cell lines it has been shown to be 
highly variable and, in the case of generation of neuronal cells, commonly displaying 
neuronal subtype heterogeneity and functional immature phenotypes 
275
. Last, 
transplantation of iPS-derived cells may lead to teratoma (tumor) formation when 
differentiation protocols are inefficient and part of the transplanted cells remains 
undifferentiated 
30
. On the other hand, direct conversion approaches are faster than the 
iPS generation methods and, when reprogramming efficiencies are improved, high 
number of patient-derived cells can be generated. Direct conversion is, in part, faster 
than the iPS strategy due to the fact that the latter requires a two-step process 
(reprogramming and differentiation), while the first is achieved in one single step; 
however, scale-up from patient´s somatic cells is not possible as they have limited 
proliferation capacity, representing a limitation when millions of cells must be replaced. 
Additionally, transcription factor-based direct conversion allows a higher degree of 
reproducibility regarding e.g. neuronal subtype specification 
275
. For human therapy 
development, both approaches require the application of integration-free gene delivery 
methods to avoid mutagenesis. Potentially, in vivo direct conversion of endogenously 
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present cells in the organ to be repaired would eliminate the process of in vitro culturing 
and, more importantly, the problems associated with transplantation (Figure 3.1, 3.4). 
 
 
 
 
Figure 3.4: Cell reprogramming approaches. 
 
 
 
3.9. Non-retroviral methods for cellular reprogramming 
 
Retroviral constructs are excellent tools to force expression of reprogramming 
molecules by incorporation of DNA sequences into the host cell´s genome 
294
. 
However, DNA integration of both i.e. transcription factors and retroviral sequences can 
lead to undesired side effects such as insertional mutagenesis and thereby tumor 
formation 
295
.  In addition, retroviral integration can promote expression of unwanted 
genes if certain loci are targeted 
 295
. Also it might be necessary to silence the expression 
of exogenous genes which are required at early stages to promote differentiation but 
impair functional maturation 
295
. Therefore, an approach relying on classical retroviral 
transduction cannot be used for potential cell-based replacement therapies. Some 
alternatives have been proposed and are listed below: 
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1, Excision: the principle of this approach is to allow transgene integration, followed by 
their excision from the host genome once reprogramming has occurred. One approach 
relies on the activitiy of the Cre recombinase at the loxP site, which has been 
successfully tested on the generation of patient-derived iPSC 
296
. However, a loxP site, 
as well as some residual viral DNA, remains in the iPSC´s genome and therefore 
potential insertional mutagenesis cannot be excluded 
296
. An alternative method is the 
use of a tranposon/tranposase approach, the so called PiggyBac system 
297
. The 
PiggyBac construct is capable of excising itself completely without leaving any 
remnants of exogenous DNA in the iPSC´s genome. The PiggyBac 
transposon/transposase system requires only the inverted terminal repeats flanking a 
transgene and transient expression of the transposase enzyme to catalyse insertion or 
excision events. The PiggyBac system shows comparable efficiency to retroviral 
methods with the benefit of increased safety 
297
 .  
2, Adenoviral methods: unlike retroviruses, adenoviruses do not incorporate their 
genome into the host DNA
 295
; therefore, there is no need for excision and represents a 
method which substantially reduces the risk of tumor formation. Despite the low 
reprogramming efficiencies using this method, it proves to be a viable and safer 
alternative to retroviral-integration strategies 
295
.  
3, Protein transduction: a DNA independent method which replaces gene delivery by 
direct protein activity. A fusion protein consisting of a reprogramming factor and a cell-
penetrating peptide (CPP), which facilitates cellular uptake of various molecular cargo, 
can be generated and applied directly to the target cell (both in vivo and in vitro)
 298
. The 
incorporation of the fusion protein into the cell occurs commonly through endocytosis. 
The first described CPP was the trans-activating transcriptional activator (Tat) from the 
Human Immunodeficiency Virus 1 (HIV-1) 
299
. CPPs typically have an amino acid 
composition that contains a high relative abundance of positively charged amino acids 
such as lysine or arginine. The absence of DNA intermediates would eliminate aberrant 
gene expression by transgene reactivation as well as any tumor formation risk; however, 
the use of this system is limited by the lack of cell specificity, insufficient understanding 
of the uptake mechanism and a very low reprogramming efficiency 
298
.  
4, RNA-mediated reprogramming: Transcriptome Induced Phenotype Remodelling 
(TIPeR) is a method based on the ability of transfected RNA (mRNA, miRNA, etc.) to 
produce cell-to-cell phenotypic conversion 
300
. This approach displays a number of 
advantages in comparison with DNA-based reprogramming methods. There is no 
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requirement for a vector or promoter-driven regulation, and mRNA does not need to be 
directed to the nucleus reducing approach complexity 
300
. While precise control of 
expression cannot be achieved in DNA-based strategies, known and specific amounts of 
synthesized mRNA can be applied; also several RNAs can be added in multiple ratios 
300
. This approach may allow the use of RNA populations with edited and spliced forms 
of RNAs with specific reprogramming potential. As RNA is transiently present in the 
cell cytoplasm, exogenous influence can be efficiently removed. Importantly, no 
integration to the genome or DNA damage occurs, minimizing the risk of malignancy. 
This reprogramming strategy carries, however, some disadvantages such as a, the 
requirement of increased RNA stability (i.e. poly-adenylation) for intracellular 
translational stability; b, RNA addition may need to be repeated multiple times; and c, 
transient inhibition of the host transcriptional machinery may be required to facilitate 
TIPeR
 300
.  
 
3.10. Perspectives for direct lineage conversion strategies 
The results shown in this thesis and the work of others in regard to the ability of somatic 
cell types to be converted into other cell types by the presence of exogenous 
transcription factors raise important questions which have to be addressed in order to 
design safe clinically applicable strategies. Considering that different somatic cells 
display different patterns of chromatin modifications, it is not yet clear how 
transcription factors find their binding sites and exert their activities; it is likely that 
these proteins have the ability to modify chromatin, thereby facilitating their access to 
certain loci; this hypothesis might partially explain the ability of the reprogramming 
factors to also down-regulate the expression of the transcriptional program of the 
starting cell.  It is essential to determine whether the reprogramming process faithfully 
mimics terminal differentiation of the cell type to be generated; detailed gene expression 
profiles must be performed in order to ensure that reprogrammed cells are identical to 
their native counterparts; in line with this aspect of reprogramming, also epigenetic 
patterning must be taken in consideration when using different starting cell types, which 
might have an influence in the phenotype of the reprogrammed cell. It is also important 
to determine whether some cells are more susceptible to lineage conversion approaches  
and how important cell division is for an efficient reprogramming process. Last, in all 
examples of iPS reprogramming and lineage conversion approaches, human cells seem 
to be more refractory to reprogramming than cells isolated from other species 
301
 ; since 
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the goal of these experiments is to develop therapies to treat human diseases, it is 
critical to understand the molecular barriers to make human cells more amenable to 
lineage conversion, differentiation and maturation.  
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4.  Materials and methods 
 
4.1. Standard Solutions  
 
Phosphate buffered Saline (PBS): 
400 g NaCl (1.37 mol/l), 10g KCl (0.02 mol/l), 10 g K2HPO4 (0.015 mol/l), 58.75 g 
Na2HPO4 x 2H2O (0.066 mol/l) were dissolved in 5 liter millipore water and autoclaved 
in 1l-bottles. This 10x PBS stock was diluted 1:10 with autoclaved Millipore water to 
around 0.15 M 1x PBS. 
Lysis buffer for tail biopsies (10 ml): 
1 ml 1 M Tris HCL pH 8.5, 100 μl 0.5 M EDTA, 200μl 10% SDS, 2 ml 1 M NaCl, 
6.6ml H2O (autoclaved) are stored together at RT in one solution. Before lysis 100 μl 
Proteinase K (10 mg/ml) was added freshly. 
Tris 10 mM for DNA (1 l): 
1,211 g Trisbase (M=121.1 g/mol) dissolved in 1 liter Millipore water. pH was adjusted 
to 8.0 with HCl. 
Electrophoresis buffer (1 l) for Western Blot: 
30.3 g Trizma, 144 g Glycine, and 10 g SDS are dissolved in 1 liter of water. pH was 
adjusted to 8.45.  
Sample buffer for Western Blot: 
2 ml 1 M Tris-HCl pH 8.5, 8 ml 20% SDS, 5 ml Glycerol, 1.6 ml ß-Mercaptoethanol, 
3.4 ml H2O, 50 mg Bromphenolblue. Store aliquots at -20°C. 
TBST for Western Blot: 
100 ml TBS 10x [1 l: 12.1 g TRIS-Base and 87.8 g NaCl are dissolved in 900 ml 
autoclaved water and pH is adjusted with 5 M HCl to pH 8.0. Autoclave.], 10 ml 20% 
Tween [200 ml H2O and 50 ml Tween 20], and 900 ml H2O are mixed. 
Para-Formaldehyde (PFA) 4% (1 l): 
PFA was diluted with autoclaved Millipore water from a frozen (-20°C) 20% PFA stock 
in 50 ml aliquots prepared according to the following protocol: 67 g Na2HPO4 x 2H2O 
were dissolved in 800 ml water thereby heated up to 60°C (temperature control!). 200 g 
PFA (Sigma) was added and stirred for around 5 minutes, until the cloudy solution was 
homogenous. Around 18 g of NaOH pellets were added until complete dissolvent of 
PFA. The pH was adjusted to 7.4 with 37% HCl. 
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4.2. Surgery 
 
Brain tissue was acquired directly from the operating room. Specimens of cerebral 
cortex (frontal and temporal lobe) of 30 patients aged between 19 and 70 years of both 
sexes were obtained from standard neurosurgical approaches to deep-seated, non-
traumatic, non-malignant lesions or epilepsy surgical procedures. The study was 
approved by the ethical committee of the Medical Faculty of the LMU Munich and 
written informed consent was obtained from all patients. 
 
 
 
Figure 4.1: The human brain and the mouse brain: lateral and sagital views (Modified from John F. 
Cryan & Andrew Holmes, Nature reviews/Drug discovery 2005). 
 
 
4.3. Cell cultures from adult human, rat and mouse cerebral cortex  
 
After removal of the meninges, tissue was dissected and dissociated mechanically. 
Subsequently, cells were centrifuged for 5 min at 1000 rpm, re-suspended, and plated in 
a medium consisting of DMEM high glucose with GlutaMAX (Gibco), 20% fetal calf 
serum (Gibco), penicillin/streptomycin (Gibco). Originally, we also added 10 ng/ml 
epidermal growth factor (EGF, Roche) and fibroblast growth factor 2 (FGF2, Roche) to 
the medium to enhance the cell proliferation during expansion. However, we noted that 
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pericyte-derived cells could be expanded without treatment with these factors with 
similar reprogramming efficiencies and thus both factors were omitted from the 
medium. After expansion for 2-3 weeks as adherent culture under normoxygenated 
conditions, cells were harvested using trypsin/EDTA (Gibco) and either plated onto 
poly-D-lysine (Sigma-Aldrich) coated glass coverslips at a density of 50,000 cells per 
coverslip (in 24-well plates; BD Biosciences) in the same medium as above for 
reprogramming experiments or passaged for further expansion (up to five times in this 
study). As for the human specimens, gray matter of the mouse (BL6) or rat (Wistar) 
cerebral cortex was dissociated mechanically. The subsequent steps of culturing were 
identical. 
 
4.4. Co-culture with E14 mouse cortical neurons 
 
For co-culture experiments, E14 mouse cerebral cortices were dissected and dissociated 
mechanically with a fire-polished glass Pasteur pipette. Mouse cells were added to the 
human cultures 20 days after retroviral transduction at a density of 10.000-50.000 cells 
per coverslip. Electrophysiological recordings and/or immunocytochemistry were 
performed 39-47 days post retroviral infection. Experiments were repeated with 3 
independent patients. 
 
4.5. DNA preparations  
 
Plasmid preparations  
Plasmid preparations were carried out using the QIAGEN Mini Kit. The DNA pellet 
was resuspended in 30-50μl dist. H2O or TE buffer. For larger amounts of DNA the 
QIAGEN Maxi Kit was used and the DNA resuspended in 300-500μl TE buffer.  
 
Transformation of bacteria using heat shock  
For the transformation of competent bacteria (TOP10, Invitrogene), one frozen aliquot 
(50µl) of bacteria was thawed on ice. 10 minutes later, 1-50ng of plasmid DNA was 
added to the bacteria and incubated on ice for 30min. For heat shock, the mixture was 
put on 42°C in a water bath for 90s. Immediately after, the bacteria were placed on ice, 
diluted with 1ml LB medium and incubated while shaking at room temperature for 30-
60min. 
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Agarose gel electrophoresis  
Agarose gels were prepared according to the expected fragment size with 0.8-2.0% 
agarose in TAE buffer (50X Stock: 2M Tris, 50mM Glacial acetic acid, 50mM EDTA). 
Heating in the microwave dissolved the agarose. Once the solution cooled down, 5μl 
ethidiumbromide (EtBr)-solution (EtBr=1mg/μl, final concentration: 0.005%) were 
added, mixed by swirling and poured into a prepared gel chamber avoiding bubbling. 
Loading of the samples on the gel was carried out by mixing the DNA solution with 
loading buffer (60% Glycerol, 2% SDS, 0.2% bromine phenol blue, 100mM EDTA). 
Separation of the DNA samples was carried out at a voltage of 100V for ca. 30-45min. 
Under UV light, fluorescent DNA fragments were documented with a BioRad Gel 
documentation system and, if necessary, removed from the gel under low intensity- UV 
light to avoid UV-induced mutations.  
 
4.6. Retroviral particle preparation 
 
The VSV-G (vesicular stomatitis virus glycoprotein)-pseudotyped retrovirus preparation 
with GPG293 cells only requires the addition of the retroviral expression plasmid vector.  
Additional viral genes are integrated in the genome of this cell line 
294,302
. Cells were 
cultured in DMEM/high glucose/Glutamax (Gibco) containing 10% FCS (Invitrogen, 
heat inactivated at 56°C for 30 min), 1X Non-Essential Amino Acids (NEAA, 100 X, 
Gibco), 1X Sodium-Pyruvate (100 X, Gibco). In addition, cells were submitted to a 
triple selection of antibiotics: 1 mg/ml penicillin/streptomycin (Gibco), 1 mg/ml 
tetracycline (for repression of the VSVG production, Sigma) 2 mg/ml puromycin (for 
selection of  the integrated VSVG gene and Tet-repressor which regulates VSVG 
expression, Sigma) and 0.3 mg/ml G418 (=Geneticin, for selection of the integrated 
MMLV genome -gagpol-, Gibco). Retroviral constructs were transfected with 
Lipofectamine 2000 (Invitrogene) into the GPG293 cell line and 48hours later 
supernatant harvested. After filtration through a 0,45 µm low protein-binding PVDF 
filter (Millipore), the supernatant was subsequently ultracentrifuged a 50000 x g for 
90min at 4°C (Beckmann, SW40Ti rotor). Pellet containing retroviral particles was 
resuspended in TBS, aliquoted and stored at -80°C. 
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4.7. Retroviral transduction 
 
The transcription factors Mash1 or Sox2 were expressed under control of an internal 
chicken β-actin promoter with cytomegalovirus enhancer (pCAG) together with DsRed 
located behind an internal ribosomal entry site (IRES) 
110
. The Mash1 coding cDNA was 
subcloned from the pCLIG-Mash1 construct into the EcoRI site of the pSKSP shuttle 
vector, from where it was then subcloned between the 5′SfiI and 3′PmeI restriction sites 
of the pCAG retroviral vector to generate pCAG-Neurog2-IRES-DsRed. The Sox2 
coding cDNA was subcloned from the pLIB-Sox2 construct
303
, also used in fate-
mapping experiments, and inserted into the pCAG retroviral vector following the same 
cloning strategy to generate pCAG-Mash1-IRES-DsRed. The coding region of the 
human Neurog2 was subcloned into pMX-IRES-GFP retroviral vector between BamHI 
and EcoRI restriction sites. The coding sequence of mouse E47 was subcloned into 
pMX-IRES-GFP between BamHI and EcoRI sites. The fusion construct corresponding 
to the REST coding sequence lacking its repressor domain and VP16 located at REST´s 
3´end was subcloned into the pMX-IRES-GFP retroviral vector between XhoI and SacII 
sites. For control, cultures were transduced with a virus encoding only DsRed behind an 
IRES (pCAG-IRES-DsRed).  
 
 
Figure 4.2: Retroviruses are efficient tools for delivering heritable genes into the genome of dividing 
cells. (Left) The pMX-GFP retroviral vector is based on Moloney murine leukemia virus (MMLV). The 
vector provides the viral package signal, transcription and processing elements. The viral env gene, 
produced by the package cell line, encodes the envelop protein, which determines the viral infectivity 
range. Transfection into a package cell line produces high-titer, replication-incompetent viruses. MCS 
(multiple cloning site). Cell Biolabs, INC. (Right) CAG-Mash1-IRES-DsRed retroviral vector. 
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Retroviral transduction of cultures was performed 2-3 h after plating on glass coverslips. 
Expression of the transcription factors was confirmed by immunocytochemistry. Twenty 
four hours after transduction, the medium was replaced by a differentiation medium 
consisting of DMEM high glucose with GlutaMAX, penicillin/streptomycin and B27 
supplement (Gibco). Cells were allowed to differentiate under low oxygen conditions 
(5% O2, 5% CO2) (Galaxy 170R, New Brunswick). 
 
4.8. Immunocytochemistry 
 
Cell cultures were fixed in 4 % paraformaldehyde (PFA) in phosphate buffered saline 
(PBS) for 15 min at room temperature. Cells were first pre-treated in 0.5% Triton X-100 
in PBS for 30 min, followed by incubation in 10% goat serum and 0.5% Triton X-100 in 
PBS for 30 min. Primary antibodies were incubated on specimen for 1 h at room 
temperature or overnight at 4°C in 10% goat serum, 0.5% Triton X-100 in PBS. After 
extensive washing in PBS, cells were incubated with appropriate species- or subclass-
specific secondary antibodies conjugated to fluorophores. Coverslips were finally 
mounted onto a glass slide with an anti-fading mounting medium (Aqua Poly/Mount; 
Polysciences, Warrington, PA).  
 
4.9. Immunohistochemistry  
 
Human brain tissue specimens were transferred into 4% paraformaldehyde and 
incubated for 48 h at 4° C. Thereafter, specimens were embedded in Tissue-tek (OCT 
compound, Sakura) and 20μm thick cryostat sections were cut. Mice were anesthetized 
and transcardially perfused with 4% paraformaldehyde (PFA). Brains were collected, 
shortly post-fixed in 4% PFA and 20μm thick cryostat sections were cut. Sections were 
incubated with primary antibodies over night at 4ºC. After washing, secondary staining 
was performed using appropriate secondary antibodies.  The following primary 
antibodies were used: chicken anti-Green Fluorescent Protein (Aves Labs, 1:1000), 
rabbit anti-Red Fluorescent Protein (Chemicon, 1:500), rabbit monoclonal anti-PDGFRβ 
(Cell Signalling, 1:200), mouse anti-Vimentin (Dako, 1:600), mouse anti-αSMA 
(Sigma-Aldrich, 1:400,), rabbit anti-NG2 (Millipore, 1:400), rabbit anti-hGFAP (Sigma-
Aldrich, 1:600),  rabbit  anti-Sox2 (Chemicon, 1:1000), mouse anti-βIII-tubulin (Sigma-
Aldrich, 1:400), mouse anti-Mash1 (Jackson-Price, 1:200), rabbit anti-CD146 (Abcam, 
1:400), mouse anti-CD31 (Dako, 1:100), rat anti-CD31 (BD Pharmingen, 1:400), mouse 
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anti-MAP2 (Millipore,  1:200), mouse anti-NeuN (Millipore, 1:200), rabbit anti-GABA 
(Sigma, 1:500), rabbit anti-Calretinin (Millipore,1:500), rabbit anti- vGluT1 (Synaptic 
Systems, 1:1000),  and chicken anti-β-galactosidase (Abcam, 1:1000).  Secondary 
antibodies conjugated to: Alexa Fluor 488 (Invitrogen, 1:500), Cy3, Cy5, FITC, TRITC 
(Jackson ImmunoResearch, 1:500), or biotin (1:500, Jackson ImmunoResearch or 
Vector Laboratories) for 1h in the dark at room temperature, followed by extensive 
washing in PBS. Following treatment with secondary antibodies conjugated to biotin, 
cells were subsequently incubated for 2h at room temperature with AMCA streptavidin 
(1:200, Vector Laboratories). Nuclei were stained with 4′,6-Diamidino-2-phenylindole 
(DAPI) (Sigma Aldrich, 1:10000).  
 
4.10. Preparation of genomic DNA from tissue  
 
The preparation of genomic DNA requires the lysis of the cells composing the tissue, 
precipitation of the DNA and its subsequent purification. The lysis step is carried out using 
SDS-containing buffers, supplemented with proteinase K to remove DNA-associated and 
other proteins. The incubation is performed at 55°C, the optimal temperature for the 
proteinase activity. Following, DNA is precipitated by addition of salt and ethanol. 
Afterwards, the DNA is washed with ethanol and dissolved in water or buffer and can be 
frozen a -20°C. 
 
4.11. Transgenic animals and tamoxifen induction 
 NG2-EYFP: Gray matter of the cerebral cortex of adult heterozygous NG2-
EYFP knock-in mice was dissected and subsequently cultured as described 
above.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   Figure 4.3: Homologous recombination of the murine NG2 gene 
232
. 
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 TNAP-CreERT2: Postnatal Tg:TN-AP-CreERT2:R26RNZG and Tg:TN-AP-
CreERT2:R26R
EYFP
 mice 
233
 were injected subcutaneously with 0.25mg of 
tamoxifen, diluted in corn oil for 3 consecutive days at 6, 7 and 8 days after birth 
to induce Cre-mediated  recombination. At postnatal stage P25, Tg:TN-AP-
CreERT2:R26R
NZG
 were sacrificed and the expression of nuclear ß-
Galactosidase analyzed in vivo. Gray matter of the cerebral cortex of adult 
Tg:TN-AP-CreERT2:R26R
EYFP 
animals was dissected and cultured as decribed 
above. 
 
 
 
 
 
 
 
 
 
 
 
      Figure 4.4: Scheme of the cloning strategy used to obtain mice Tg:TN-AP-CreERT2 
233
. 
 
4.12. Microscopy  
 
Immunocytochemical and immunohistochemical stainings were first examined with an 
epifluorescence microscope (BX61, Olympus) equipped with the appropriate filter sets. 
Stainings were further analyzed with a LSM710 laser-scanning confocal microscope 
(Carl Zeiss,). Digital images were captured using the ZEN software (Carl Zeiss). Cell 
counts were performed using a 40X objective in at least five fields of view randomly 
selected from each coverslip. At least 3 independent experiments were counted.  
 
4.13. Flow cytometry and FACS sorting 
 
Human brain-derived cells were detached from the culture dish using 0.25% trypsin for 
4-6 minutes and subsequently 1-3 x 10
5
 cells were resuspended in 100 µl staining 
solution (PBS plus 0.5% BSA). For surface marker analysis, primary antibodies (PE-
conjugated CD140b (PDGFR-β) (1:100, BD Biosciences) and APC-conjugated CD34 
(1:100, BD Biosciences) were added individually and cells were incubated for 20 min at 
4°C. After washing three times in staining solution, cells were resuspended in 500 µl 
staining solution and subjected to surface marker analysis using a FACS Aria (BD). The 
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same setup was used to sort cells after co-staining with conjugated antibodies against 
CD34 and CD140b. APC-conjugated and PE-conjugated isotype control antibodies 
(1:100, AbD Serotec) were used to gate the proper populations. CD34-
negative/CD140b-positive as well as double negative cells (CD34-negative/CD140b-
negative) were sorted. Following sorting, cells were plated on PDL-coated glass cover 
slips on 24-well plates.  
 
4.14. Reverse Transcription (RT)-PCR Assay  
 
Total RNA was extracted with RNeasy MicroKit (Qiagen), according to the 
manufacturer’s instructions. Total RNA was retro-transcribed as follows: 1-1,5 μg was 
adjusted to a final volume of 10μl with DEPC water and incubate at 65°C for 15 
minutes, then transferred to ice; in a separate tube, 4μl of 5X First strand Buffer 
(Invitrogen), 2μl DTT 0,1M, 2μl dNTPs (10mM), 0,8μl Random Primers (500μM, 
Roche), 0,2μl RNasiOut (Invitrogen) and 1μl of cDNA MMLV-Retrotranscriptase 
(Invitrogen) were combined. This mixture was added to the RNA-water mixture and 
incubated at 37°C for 1 hour. The reaction was stopped by incubating the sample at 
70°C for 10 minutes. The obtained cDNA was diluted one to ten, and 2μl was used in 
each PCR sample. Retrotranscribed cDNA was used as template, and the PCR reaction 
was performed as following: 
 
 
Mix Amount 
DNA 2μl 
10X Buffer 2μl 
Primer Forward (10μM) 1μl 
Primer Forward (10μM) 1μl 
dNTPs (2μM) 1μl 
TaqPolymerase 0,2μl 
H2O 12,8μl 
Total 20μl 
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Gene Forward Reverse 
GAPDH CGCATCTTCTTGTGCAGTG GTTCAGCTCTGGGATGAC 
Sox-2 ACCTACAGCATGTCCTACTCG GGGCAGTGTGCCGTTAATGG 
RGS5 ATGTGTAAGGGACTGGCAGC TACTTGATTAGCTCCTTAT 
Acta2 GATCCTGACGCTGAAGTATCCG TACCCCCTGACAGGACGTTGT 
Csrp2 CCTCGGTCAGACCTCGTTAGC CACAGTAGTGAGCGCCATAAACG 
Axl GGTCGCTGTGAAGACCATGA CTCAGGTACTCCATACCACT 
Annexin5 GAAGCAATGCTCAGCGCCAGG TATCCCCCACCACATCATCTTC 
PdgfRBeta AGCTACATGGCCCCTTATGA GGATCCCAAAAGACCAGACA 
 
Table 4.1: Mouse oligonucleotide primers for RT-PCR assay. 
 
4.15. Quantitative RT-PCR assay 
 
Total RNA was extracted with RNeasy Plus MicroKit (Qiagen), according to the 
manufacturer’s instructions. One µg of total RNA was retro-transcribed using Super-
ScriptIII Reverse Transcriptase (Invitrogen) and random primers. Each cDNA was 
diluted one to ten, and 1l was used for each real-time reaction. Messenger RNA 
quantitation was performed on a LightCycler480 (Roche) using the Light Cycler 
TaqMan Master kit (Roche) according to the manufacturer’s instructions. The amount of 
each gene was analyzed in triplicate. Data analysis was performed with the Ct 
method. 
 
 
Gene Accession 
number 
Forward primer Reverse primer Ampli
con 
GAPDH NM_002046 agccacatcgctcagacac gcccaatacgaccaaatcc 66 
PDGFRβ NM_002609 cccttatcatcctcatcatgc ccttccatcggatctcgtaa 60 
     VIM 
 (Vimentin) 
NM_003380 gtttcccctaaaccgctagg agcgagagtggcagagga 68 
SOX2 NM_003106 atgggttcggtggtcaagt ggaggaagaggtaaccacagg 60 
SOX9 NM_000346 aacgccttcatggtgtgg tctcgctctcgttcagaagtc 124 
ASCL1 
(Mash1) 
NM_004316 cgacttcaccaactggttctg atgcaggttgtgcgatca 89 
MECAM 
(CD146) 
NM_006500 gggtaccccattcctcaagt cagtctgggacgactgaatg 91 
GFAP NM_002055 ccaacctgcagattcgaga tcttgaggtggccttctgac 63 
P75 NM_002507.2 tcatccctgtctattgctcca tgttctgcttgcagctgttc 93 
SOX1 NM_005986.2 tcttttgggttggtttgttaattt aatataactccgccgtctgaag 76 
PROM1 
(CD133) 
NM_006017 tccacagaaatttacctacattgg cagcagagagcagatgacca 77 
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CSPG4 
(NG2) 
NM_001897 gagaggcagctgagatcagaa tgagaatacgatgtctgcaggt 77 
ACTA2 
(αSMA) 
NM_001141945.1 ctgttccagccatccttcat tcatgatgctgttgtaggtggt 70 
CD34 NM_001773.2 tggctatttcctgatgaatcg aagagtggtcagggttccag 75 
S100B NM_006272.2 ggaaggggtgagacaagga ggtggaaaacgtcgatgag 73 
NES 
(Nestin) 
NM_006617.1 tgcgggctactgaaaagttc tgtaggccctgtttctcctg 64 
PAX6 NM_000280.3 ggcacacacacattaacacactt ggtgtgtgagagcaattctcag 71 
OLIG2 NM_005806 agctcctcaaatcgcatcc atagtcgtcgcagctttcg 70 
SOX10 NM_006941.3 ggctcccccatgtcagat ctgtcttcggggtggttg  85 
 
Table 4.2: Human oligonucleotide primers used in qRT-PCR analysis. 
 
4.16. Electrophysiology  
 
Electrophysiological properties of neurons derived from reprogrammed pericyte-like 
cells were analyzed following retroviral transduction. The electrode is composed of a 
glass micropipette whose tip is sealed onto the surface of the cell membrane rather 
inserted through it. The interior of the pipette is filled with a solution matching the ionic 
composition of the neuron´s cytoplasm, with a silver wire placed in contact with the 
solution which conducts the electric current to the amplifier. Measurement of changes in 
voltage or in current can be carried out by current-clamp or voltage-clamp mode, 
respectively. In current-clamp mode, the membrane potential is free to vary and the 
amplifier records voltage (mV) changes generated spontaneously or as a result of 
current injection (pA) in the cell. In voltage clamp, in contrast, the membrane potential 
is fixed at a certain value (mV) allowing the measurement of ionic current flow (pA) 
through the cell membrane at any given voltage. Single perforated patch-clamp 
recordings were performed at room temperature with amphotericin-B (Calbiochem) for 
perforation. Micropipettes were made from borosilicate glass capillaries (Garner, 
Claremont, CA, USA). Pipettes were tip-filled with internal solution and back-filled 
with internal solution containing 200 mg/mL amphotericin-B. The electrodes had 
resistances of 2–2.5 MV. The internal solution contained 136.5 mM K-gluconate, 17.5 
mM KCl, 9 mM NaCl, 1 mM MgCl2, 10 mM HEPES, and 0.2 mM EGTA (pH 7.4) at 
an osmolarity of 300 mOsm. The external solution contained 150 mM NaCl, 3 mM 
KCl, 3 mM CaCl2, 2 mM MgCl2, 10 mM HEPES, and 5 mM glucose (pH 7.4) at an 
osmolarity of 310 mOsm. The recording chamber was continuously perfused with 
external solution at a rate of 0.5 mL/min. Cells were visualized with an epifluorescence 
microscope (Axioskop2, Carl Zeiss) equipped with the appropriate filter sets. For patch 
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clamp recordings, virally transduced cells were selected on the basis of their DsRed 
and/or GFP immunoreactivity. Digital pictures of the recorded cells were acquired using 
a digital camera (AxioCam, Carl Zeiss). Signals were sampled at 10 kHz with Axopatch 
200B patchclamp amplifiers (Axon Instruments, Foster City, CA, USA), filtered at 5 
kHz and analyzed with Clampfit 9.2 software (Axon Instruments). For assessing a cell’s 
ability to fire APs, cells received depolarizing step-current injections and were treated 
with the sodium channel antagonist TTX (Tetrodotoxin), revealing the neuronal sodium 
channel component responsible for the generation of action potentials. AP amplitudes 
were measured by subtracting the threshold voltage of the AP from the AP maximum 
amplitude. For determining input resistance, hyperpolarizing currents of small 
amplitudes were injected into the cells under current clamp condition at a holding 
potential of 270 mV and input resistances were calculated from the corresponding 
voltage deviation. To examine spontaneous synaptic input into a given neuron, cells 
were kept in voltage clamp at a holding potential of 270 mV and synaptic events were 
recorded throughout a period of 1 to 5 min. To determine the nature of the synaptic 
responses, neurons were step-depolarized as described above and we assessed whether 
responses could be abolished in the presence of the AMPA/kainate receptor antagonist 
CNQX (5 mM). Finally, the recovery of the synaptic response was assessed following 
washout of the pharmacological drugs.  
 
4.17. Time-lapse video microscopy 
 
Time-lapse video microscopy of sorted PDGFRß-positive human cells was performed 
with a cell observer (Zeiss) at a constant temperature of 37
o
C and 8 % CO2. Phase 
contrast images were acquired every 5 minutes, and fluorescence pictures every 7.5 
hours for 14 days using a 10x phase contrast objective (Zeiss), and an AxioCamHRm 
camera with a self-written VBA module remote controlling Zeiss AxioVision 4.7 
software 
305
. Movies were assembled using Image J 1.42q (National Institute of Health, 
USA) software and are played at speed of 3 frames per second.  
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4.18. Western Blot 
 
Samples were loaded on SDS-PAGE gels. 
Collecting Gel 4 % (7.5 ml): 4.575 ml clean H2O, 0.975 ml acryl amide (Bio-Rad), 
1.875 ml gel buffer pH 6.8 (0.5 M Tris pH 6.8), 37.5 μl 20 % SDS, 37.5 μl APS, 7.5 μl 
TEMED (Biorad). 
Separation Gel 12 % (15 ml): 5.1 ml clean H2O, 6 ml 30 % acryl amide, 3.75 ml gel 
buffer pH 8.8 (1.5 M Tris pH 8.8), 75 μl 20% SDS, 75 μl 10 % APS, 7.5 μl TEMED. 
Western Blot Gels run under the following conditions: 1.5h, 120V. Gels were 
equilibrated in Transfer buffer (200 ml MetOH, 100 ml electrophoresis buffer and 700 
ml H20) for 30 minutes. 
Blotting: Membranes (PVDF, Biorad) were first incubated in MetOH; 30 minutes later, 
replaced by transfer buffer. Blot was performed in semi-dry conditions (Bio-Rad): 320 
mA per gel / 15 V limited, 45 minutes. Immediately after the end of the blot PVDF 
membranes were washed three times for 5 minutes in 1 x TBST. 
Detection: Membranes were prepared for antibody staining by blocking in 1 x TBST 
containing 5 % milk powder (Bio-Rad) for 1 hour at room temperature. The primary 
antibody rabbit against Sox2 (1:1000 in TBST containing 5 % milk powder) was 
incubated overnight at 4°C; washed out the next day for three times 15 minutes in 1x 
TBST. The secondary HRP-labelled antibody (anti-rabbit 1:10.000 in TBST containing 
5 % milk powder) was applied for one hour at room temperature. Membranes were 
washed again three times in 1x TBST for one hour minutes. Detection of proteins bound 
onto the membrane was performed in a dark chamber using an ECL-Plus detection Kit 
(Amersham) (2 ml Solution A; 50 μl Solution B) and the x-ray film (Amersham photo 
paper) developed at different exposure time points. 
 
4.19. Lentiviral construct containing microRNAs against Sox2 cDNA 
 
Four different microRNAs against the coding sequence of Sox2 were designed using the 
software BLOCK-iT™ RNAi Designer (Invitrogene 
TM
) and the corresponding 
oligonucleotide sequences chemically generated. Every oligonucleotide sequence was 
cloned into pcDNA™6.2 (Invitrogene 
TM
) and transfected into HEK cells, together with 
a plamid over-expressing Sox2 to assess microRNA-induced Sox2 down-regulation. 
Next, all four sequences were subcloned in tandem into the lentiviral vector pLENTI7.3  
(Invitrogene 
TM
). 
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Sox2 cDNA target sequences (green): 
 miRNA 230:          TGGGCGCGGAGTGGAAACTTT 
 miRNA 313:         AAGGAGCACCCGGATTATAAA 
 miRNA 357:         GACGCTCATGAAGAAGGATAA 
 miRNA 477:     GGACAGCTACGCGCACATGAA                                               
 
 
Example strategy miRNA 230 (reverse sequences in red): 
Top Strand 
 5'- TGCTGAAAGTTTCCACTCCGCGCCCAGTTTTGGCCACTGACTGACTGGGCGCGGTGGAAACTTT -3'  
 
Bottom Strand 
 5'- CCTGAAAGTTTCCACCGCGCCCAGTCAGTCAGTGGCCAAAACTGGGCGCGGAGTGGAAACTTTC -3'  
 
ds Oligo  
5'- TGCTGAAAGTTTCCACTCCGCGCCCAGTTTTGGCCACTGACTGACTGGGCGCGGTGGAAACTTT -3' 
         |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||      
3'- CTTTCAAAGGTGAGGCGCGGGTCAAAACCGGTGACTGACTGACCCGCGCCACCTTTGAAAGTCC -5' 
 
 
 
 
Figure 4.3: Cloning of four microRNAs in tandem into a lentiviral vector.  
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4.20. Data analysis  
 
Virally transduced cells were identified by reporter–immunoreactivity (GFP or DsRed) 
and co-localization with cell type specific antigens and subsequently quantified. The 
total number of cells counted in all experiments is indicated in the text or figure legends. 
For each analysis at least 3 independent experiments were performed. Statistical 
analyses were performed by Student’s two-tailed paired t-test using GraphPrism 4 
software. P-values smaller than 0.05 were considered significant; P-values smaller than 
0.001 were considered highly significant. Significant changes are indicated with the 
symbol * on top of the corresponding diagram bars. Error bars represent the standard 
error of the mean.  
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